https://rjrindex.com/articles/recast-re-evaluating-conditions-for-active-surveillance-suitability-as-treatment-for-dcis-clinica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-vorasidenib-in-idh-mutant-gliomas-tolerability-adverse-events-and-acce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-study-of-whole-body-mri-wbmri-as-part-of-a-multimodality-screening-program-for-indiv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/geographic-racial-and-temporal-disparities-in-cancer-and-respiratory-failure-mortality-in-the-us-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preliminary-safety-results-of-an-observational-phase-ii-study-of-concurrent-use-of-aspirin-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/late-effects-in-high-risk-neuroblastoma-survivors-who-received-mibg-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experience-and-safety-of-chemotherapy-and-immunotherapy-in-patients-with-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-tx-patterns-and-decision-drivers-in-chinese-patients-pts-with-locally-advanced-cervica 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-derived-method-for-rapidly-constructing-cervical-organoids-with-native-immune-and-mutation-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/extended-vs-standard-lymphadenectomy-in-patients-of-pancreatic-head-adenocarcinoma-undergoing-pancre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-effectiveness-of-laws-requiring-human-papillomavirus-vaccination-on-cervical-cancer-ra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-predictive-models-in-women-with-advanced-epithelial-ovarian-cancer-triaged-to-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-the-tolerability-and-toxicity-profile-of-nivolumab-in-a-black-population-with-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-registry-for-uveal-melanoma-in-lebanon-10-year-single-center-experience-of-a-major-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-patients-with-locally-advanced-and-metastatic-cutaneous-squamous-cell-carcinoma-cscc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyses-of-clinical-and-biologic-determinants-of-melanoma-bone-metastasis-mel-bone 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-valvular-heart-disease-in-adult-survivors-of-childhood-cancer-a-report-from-the-childhoo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-safety-of-two-year-fixed-duration-vs-continuous-immune-checkpoint-inhibitor-therapy-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhancing-lung-cancer-surgical-quality-insights-from-a-national-quality-improvement-collaborative 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-health-related-quality-of-life-among-individuals-living-with-non-small-cell-lung-in-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-myeloablative-and-reduced-intensity-conditioning-for-allogeneic-pbsct-in-mds-with-increase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-and-hospitalizations-with-lutetium-lu-177-vipivotide-tetraxetan-in-veterans-with-underlyi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-for-patients-with-metastatic-castration-resistant-prostate-cancer-mcrpc-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-relevance-of-aurora-kinase-a-iaurkai-expression-in-prost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-fracture-following-androgen-receptor-pathway-inhibitors-arpis-a-population-based-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/independent-effects-of-comorbidities-and-race-on-breast-cancer-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implications-of-homologous-recombination-repair-pathway-mutations-on-the-immune-microenvironment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-perspectives-a-qualitative-study-of-reasons-for-subcutaneous-preference-vs-intrave 2026-08-24 monthly 0.7 https://rjrindex.com/articles/canadian-cancer-trials-group-cctg-ind234223-pc-bets-prostate-cancer-biomarker-enrichment-and-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncology-risk-score-as-predictor-of-unplanned-readmissions 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-current-state-of-cancer-survivorship-care-and-barriers-at-an-nci-designated-cancer-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-transcriptomic-classification-of-glioblastoma-associations-with-survival-and-tumor-microe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gemini-nsclc-study-integrated-longitudinal-multi-omic-biomarker-profiling-study-of-non-small-cell-l 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gotistobart-in-combination-with-pembrolizumab-in-patients-with-advanced-melanoma-who-have-progressed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-whole-pelvic-vs-bladder-only-radiation-in-muscle-invasive-bladder-cancer-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-analysis-for-injected-and-non-injected-lesions-and-of-the-safety-and-efficacy-of-superficia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolutionary-divergence-of-the-hla-b-genotype-as-a-predictor-of-immune-checkpoint-inhibitor-ici-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-models-to-predict-skeletal-related-events-in-bone-metastasis-from-advanced-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-tenosynovial-giant-cell-tumor-an-analysis-of-the-surveillance-epidemiology-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-evaluation-of-a-multi-cancer-early-detection-assay-using-nmr-based-molecular-signatures 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-disparities-in-clinical-trials-for-fda-approved-drugs-in-colon-cancer-a-post-covid-era-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/albumin-myosteatosis-gauge-as-a-prognostic-biomarker-in-patients-treated-with-immune-checkpoint-inhi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-related-mortality-of-incarcerated-populations-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-fluoropyrimidine-and-platinum-based-chemotherapy-regimens-in-combination-with-immunoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/jak-inhibitor-for-the-treatment-of-steroid-refractory-and-life-threatening-immune-related-adverse-ev 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-and-clinical-relevance-of-metabolic-signature-subtypes-in-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-cytogenetic-associations-and-outcomes-in-multiple-myeloma-with-chromosome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-comparative-analysis-of-cardiovascular-cv-safety-and-time-to-next-treatment-ttnt-wi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patterns-of-management-of-positive-sentinel-lymph-nodes-in-breast-cancer-patients-after-the-american 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pd-l1-high-expression-on-the-prognosis-of-patients-with-locally-advanced-gastric-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-insights-into-hrher2-early-stage-breast-cancer-neoadjuvant-therapy-responses-by-mammap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-age-of-onset-and-prognosis-of-p53-mutant-myeloid-malignancies-in-african-americans 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-outcome-of-cardiovascular-risk-factors-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-the-use-of-hypomethylating-agents-prior-to-reduced-intensity-conditioning-allogeneic-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-of-exceptional-responders-er-and-non-responders-nr-to-androgen-receptor-pathway-inhibi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-survival-outcomes-of-patients-with-poor-prognosis-metastatic-germ-cell-tumours-gct 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-systemic-inflammation-in-early-stage-breast-cancer-in-the-canto-cohort-sim-cant 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-survival-outcomes-among-histological-subtypes-of-pulmonary-adenocarcinoma-a-nationwide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-experience-with-dose-adjusted-epoch-r-in-diffuse-large-b-cell-lymphoma-and-primary-medias 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-non-burkitt-non-hodgkin-lymphoma-related-mortality-in-the-united-states-over-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-jk06-a-5t4-antibody-drug-conjugate-in-patients-with-unresectable-locally-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-efficacy-and-safety-results-from-rebirth-a-phase-ii-study-of-risk-based-bladder-sparing-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-the-safety-and-tolerability-of-the-antibody-drug-conjugate-adc-mesoc2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-hypofractionated-radiotherapy-plus-tislelizumab-with-anlotinib-followed-by-adjuvant-tisl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/omx-0407-a-novel-spectrum-selective-small-molecule-kinase-inhibitor-in-advancedmetastatic-solid-tu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-metaplasia-in-adenocarcinoma-of-the-lung-a-national-cancer-database-anal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-treatment-strategies-of-cdk46-inhibitors-combined-with-endocrine-therapy-in-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-study-of-the-safety-and-pharmacokinetics-of-pas-004-a-macrocyclic-mek-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shifts-in-the-landscape-of-colorectal-cancer-burden-a-systematic-analysis-using-the-global-burden-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-asco-clinical-guidelines-authorship-and-institutional-representation-using-hemoncorg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-imprinttn-signature-with-survival-outcomes-by-race-in-basal-type-triple-negative-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-of-patients-with-her2-positive-invasive-lobular-carcinoma-in-the-altto-trial-big 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-impact-of-adjuvant-chemotherapy-regimens-for-small-t1miab-node-negative-pn0-triple 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deep-learning-to-predict-treatment-response-of-immune-checkpoint-inhibitors-from-pretreatment-chest 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-natural-language-processing-to-understand-financial-toxicity-in-cancer-care-a-thematic-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cancer-patients-messages-about-radiologypathology-reports-insights-for-ai 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-characteristics-and-survival-outcomes-in-adults-with-acute-megakaryoblastic-leuk-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-eligibility-criteria-in-randomized-controlled-trials-for-chronic-lymphocytic-leukemia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-adverse-events-related-to-immunosuppressive-treatments-among-patients-with-head-and-neck-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-into-disease-progression-in-endometrial-cancers-the-role-of-cell-proliferation-pathway-mut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/intravenous-selenium-to-prevent-oral-mucositis-in-patients-with-lymphoma-or-myeloma-undergoing-high 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-factors-associated-with-distant-recurrence-in-patients-with-intimal-sarcoma-at-a-tertiary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/economic-impact-and-mortality-outcomes-of-palliative-care-integration-among-cancer-patients-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-cachexia-and-anorexia-in-hospitalized-female-patients-with-breast-cancer-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/transfusion-related-cost-and-time-burden-offsets-in-patients-with-myelofibrosis-treated-with-pacriti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biological-determinants-of-immune-exclusion-in-non-small-cell-lung-cancer-an-analysis-of-the-precis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-quality-of-life-and-financial-toxicity-among-patients-with-gynecological-cancers-in-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-trial-of-intratumoral-adenovirus-interleukin-12-it-advil-12-and-atezolizumab-in-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cancer-related-fatigue-on-quality-of-life-of-1262-patients-with-breast-cancer-receiving-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-signature-differences-in-paired-tissues-of-triple-negative-breast-cancer-receiving-neoadj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-fih-phase-1-study-of-cusp06-a-cadherin-6-cdh6-directed-antibody-drug-conjugate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-regimen-and-cisplatin-dose-effects-on-survival-in-neoadjuvant-treatment-of-urothelial-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-lenvatinib-plus-everolimus-in-advanced-extra-pancreatic-neuroendocrine-tumors-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ng11-2-phase-ib-trial-to-preventreduce-severe-oral-mucositis-induced-by-radiotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-safety-and-efficacy-results-from-a-first-in-human-phase-12-study-of-sar445877-an-anti-pd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obx-115-engineered-tumor-infiltrating-lymphocytes-til-with-regulatable-membrane-bound-il15-mbil15 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-analysis-of-disitamab-vedotin-combined-therapy-for-her2-expressing-platinum-sensitive-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-cell-of-origin-gene-rearrangements-and-frontline-treatment-on-incidence-of-secondary-cen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-encore-multicenter-prospective-registry-of-sequential-antibody-drug-conjugates-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/peptide-receptor-radionuclide-therapy-lu-177-prrt-in-neuroendocrine-tumors-net-single-instituti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systemic-antitumor-virotherapy-pre-clinical-evaluation-of-tumor-targeting-efficacy-and-safety-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-pathology-based-ai-spatial-biomarker-to-predict-outcomes-for-immune-checkpoint-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clonevo-preoperative-abemaciclib-for-cisplatin-ineligible-muscle-invasive-bladder-cancer-mibc-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-matrix-trial-a-multicenter-randomized-phase-ii-study-of-atr-inhibition-via-tuvusertib-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-monitoring-in-participants-pts-with-ovarian-cancer-treated-with-neoa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-exploratory-clinical-study-investigating-the-neoadjuvant-treatment-of-her2-low-expressing-stage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dreamm-7-study-of-belantamab-mafodotin-plus-bortezomib-and-dexamethasone-bvd-vs-daratumumab-plus-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-significance-of-cognitive-function-assessment-in-treatment-naive-high-grade-glioma-patients-on-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/obx-115-engineered-tumor-infiltrating-lymphocyte-til-cell-therapy-with-regulatable-membrane-bound-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-validation-of-a-multi-modal-ataraxis-ai-platform-for-recurrence-prediction-in-early-stage-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-temperature-controlled-hand-foot-cryotherapy-to-prevent-chemotherapy-induced-polyneuropa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/shr-a1811-plus-adebrelimab-in-unresectable-or-metastatic-triple-negative-breast-cancer-results-from 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-hyperglycemia-on-in-hospital-outcomes-on-gastric-and-esophageal-cancer-patients-suffering 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-with-anti-pd-1-or-pd-l1-in-advanced-ovarian-cancer-oc-a-meta-analysis-of-randomized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mrd-negativity-after-end-of-induction-in-the-phase-3-phallcon-trial-a-post-hoc-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-global-phase-3-open-label-randomized-2-arm-study-comparing-the-clinical-efficacy-and-safety-of-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-clinicogenomic-profiling-of-signet-ring-cell-carcinoma-across-multiple-organ-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-survival-outcomes-with-ivosidenib-in-chinese-patients-with-idh1-mutated-intrahepatic-chol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-and-factors-associated-with-financial-toxicity-among-gastrointestinal-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-protein-biomarkers-for-early-detection-of-pancreatic-ductal-adenocarcinoma-using-longitudinal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-rw-ctdna-testing-trends-and-associated-outcomes-in-patients-pts-with-early-stage-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-and-overall-survival-os-for-zanidatamab-chemotherapy-in-her2-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-to-evaluate-the-safety-pharmacokinetics-and-efficacy-of-the-first-in-class-cyclin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-prospective-single-arm-phase-ii-study-of-adebrelimab-plus-carboplatin-and-albumin-bound-taxanol 2026-08-24 monthly 0.7 https://rjrindex.com/articles/five-year-median-follow-up-update-of-pure-01-a-phase-2-study-of-neoadjuvant-pembrolizumab-followed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-pain-and-symptom-management-in-cancer-a-data-driven-analysis-of-care-delivery-psychosoci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-randomized-study-comparing-ultra-low-dose-immunotherapy-to-standard-cytotoxic-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/8-year-outcomes-of-enzalutamide-enza-versus-a-non-steroidal-anti-androgen-nsaa-for-metastatic-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-the-interleukin-6-il-6-receptor-blocking-antibody-sarilumab-sari-in-combinat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-olomorasib-a-second-generation-kras-g12c-inhibitor-plus-cetuximab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-claudin182-expression-pd-l1-and-prognostic-implications-in-gastric-and-gastroesoph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-integration-of-microbiome-and-exosome-profiles-for-precision-diagnostics-and-therapeutics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/state-level-trends-and-associated-disparities-in-melanoma-burden-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dietary-compounds-and-patterns-associated-with-immune-checkpoint-inhibitor-ici-outcomes-in-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-bh011-after-intravesical-administration-in-patients-with-cis-andor-papillary-non-muscle 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dalpiciclib-dalp-plus-endocrine-therapy-et-as-adjuvant-treatment-for-hrher2-early-breast-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/systematic-review-and-meta-analysis-of-pd-1-and-pd-l1-inhibitors-in-triple-negative-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-jnj-79635322-jnj-5322-a-novel-next-generation-trispecific-antibody-tsab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-phase-iii-trial-evaluating-bnt142-a-first-in-class-mrna-encoded-bispecific-antibod 2026-08-24 monthly 0.7 https://rjrindex.com/articles/broad-implementation-of-ai-for-lymph-node-assessment-insights-from-a-head-to-head-comparison-of-two 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-immune-checkpoint-blockade-therapy-in-combination-with-tace-for-resectable-hepatocellula 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-cafelkibart-lm-108-an-anti-ccr8-monoclonal-antibody-in-combination-with-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/idov-safe-an-intravenously-deliverable-oncolytic-vaccinia-virus-for-solid-tumors-refractory-to-stan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perioperative-systemic-therapy-for-resectable-colorectal-peritoneal-metastases-a-multicenter-random 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-lucicebtide-st101-in-glioblastoma-patients-by-antagonism-of-cebpv-dependent-mesenchymal-ce 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radical-surgery-with-adjuvant-therapy-in-advanced-oral-tongue-cancer-survival-trends-and-functional 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-study-of-allogeneic-anti-cd19-car-t-therapy-for-patients-with-cd19-relapsedrefractory-ac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncopro-a-us-national-initiative-supporting-implementation-of-remote-symptom-monitoring-with-electr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-phase-2-study-of-casdozokitug-an-il-27-targeting-antibody-in-combination-with-toripal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-end-of-treatment-ctdna-mrd-by-phased-seq-in-dlbcl-patients-from-a-national 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifiable-renal-lesion-diagnostic-mdct-enhancement-criteria-for-pathology-prediction-and-clinical 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-immunotherapy-response-for-hepatocellular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-targeted-therapies-in-oncology-the-role-of-alectinib-in-managing-alk-positive-non-small-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-clinical-trial-of-quaratusugene-ozeplasmid-gene-therapy-and-atezolizumab-maintenance-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-erk-signaling-and-tumor-microenvironment-in-braf-altered-gliomas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-lazertinib-with-or-without-chemotherapy-for-patients-with-epidermal-growth-factor-recept 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-pharmacological-interventions-in-alveolar-soft-part-sarcoma-a-network-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multi-omic-liquid-biopsy-for-the-earlier-detection-of-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/productivity-of-national-cancer-institute-k-awardees-and-their-transition-to-independent-funding 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-specific-unmet-needs-among-older-patients-with-cancer-enrolled-in-an-outpatient-palliative-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enhanced-dysplasia-detection-in-inflammatory-bowel-disease-a-comprehensive-meta-analysis-of-dye-bas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-a-3-component-genomic-instability-score-to-individual-biomarker-scores-in-classifying 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-an-ultra-sensitive-sequencing-platform-to-detect-mutant-ikrasi-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/uncovering-the-tumor-microenvironment-tme-exploring-survival-and-immunotherapy-io-response-in-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-control-trial-to-validate-mitigation-of-chemotherapy-induced-peripheral-neuropathy-by-lim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/accelerating-and-de-risking-late-pre-clinical-drug-development-with-the-zebrafish-tumor-xenograft-z 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigation-of-pegargiminase-targeting-the-fanconi-anemia-pathway-and-its-role-in-dna-double-stran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-differential-epigenetic-landscapes-in-subtypes-of-appendiceal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploration-of-different-egfr-scores-and-their-relationship-with-prognosis-in-patients-with-urotheli 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-generated-health-data-as-a-risk-stratification-tool-real-world-multidisciplinary-care-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-camrelizumab-combined-with-radiotherapy-as-neoadjuvant-therapy-for-locally-ad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-melanoma-cells-through-g-quadruplex-formation-mechanism-and-enhanced-efficacy-of-t-oligo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-dna-5-hydroxymethylcytosine-profiling-for-the-assessment-of-colorectal-cancer-biology-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-based-clinicogenomic-analysis-of-advanced-head-and-neck-cancer-patients-treated-with-immune-ch 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographics-socioeconomic-and-treatment-patterns-for-adenocarcinoma-with-cartilaginous-and-osseou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd1-inhibitors-with-concomitant-palliative-radiotherapy-for-treatment-of-older-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-targets-singular-promise-a-comprehensive-analysis-of-bispecific-antibodies-in-solid-tumor-onc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effcacy-and-safety-results-of-a-multi-center-phase-iii-study-of-utidelone-capsule-a-novel-oral-mic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-of-head-and-neck-cancers-hncs-genetic-heterogeneity-immune-landscape-and-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/postoperative-radioiodine-rai-versus-no-radiodine-therapy-for-patients-with-low-risk-differentiate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-anlotinib-plus-third-generation-egfr-tkis-in-advanced-non-small-cell-lung-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pilot-study-of-intestinal-microbiome-alteration-with-resistant-potato-starch-rps-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sex-and-gender-influence-on-adverse-events-for-melanoma-patients-a-comprehensive-review-and-meta-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-characterization-of-her2-alterations-in-non-small-cell-lung-cancer-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/caregiver-distress-caring-for-those-who-care-for-our-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-glp-1-agonists-sglt-2-inhibitors-and-other-glucose-lowering-medications-on-cardiorenal-out 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-comparative-effectiveness-of-clinical-trial-participation-on-hospital-outcomes-among 2026-08-24 monthly 0.7 https://rjrindex.com/articles/marketing-cancer-care-a-content-analysis-of-ethical-compliance-in-television-advertising-by-top-ran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-teratoma-histology-in-postchemotherapy-residual-lesions-of-non-seminoma-testicular-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-for-cancer-patients-out-of-pocket-costs-by-cancer-diagnosis-in-traditional-medic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-assessment-of-pre-and-post-neoadjuvant-suvs-via-18f-fdg-petct-in-esophageal-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initiation-of-high-dose-chemotherapy-at-rising-tumor-markers-compared-with-radiographic-progression 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-intensity-modulated-radiotherapy-and-3d-conformal-radiotherapy-in-the-treatment-of-eso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-rurality-with-guideline-concordant-survivorship-care-receipt-among-medicare-beneficia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-cost-effectiveness-of-genetic-testing-in-high-risk-families-with-confirmed-germline-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evolving-trends-in-latin-american-oncology-clinical-trial-sites 2026-08-24 monthly 0.7 https://rjrindex.com/articles/telehealth-utilization-in-neuro-oncology-a-single-institution-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-pilot-trial-of-a-neuromodulatory-digital-therapeutic-for-individuals-with-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-telehealth-utilization-on-adherence-to-endocrine-therapies-in-privately-insured-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gh9d2-t-cell-activation-ghdtca-with-ict01-combined-with-azacitidine-venetoclax-av-for-olderunfit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/androgen-pathway-gene-expression-and-response-to-hormonal-therapy-in-prostate-cancer-swog-s1216 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-a-phase-2-study-timdarpacept-imm01-combined-with-azacitidine-aza-as-the-firs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-tumor-growth-modeling-and-informed-neural-networks-as-early-predictive-clinical-endpoints 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-modeling-by-tumor-type-comparing-performance-and-feature-importance-of-machine-learning 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeting-preventable-acute-care-events-a-study-on-which-patients-experience-emergency-visits-and-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/awareness-of-gestational-surrogacy-among-female-patients-treated-for-cancer-a-national-survey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-ai-based-computer-aided-detectiondiagnosis-ai-cad-for-breast-ultrasound-a-prospective 2026-08-24 monthly 0.7 https://rjrindex.com/articles/deepseal-empowering-clinical-researchers-to-analyze-clinicogenomic-data-with-an-intuitive-chat-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/who-benefits-from-gilteritinib-combination-therapy-amongst-flt3-supmutsup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-from-a-21-year-analysis-of-mortality-due-to-hypertension-and-esophageal-cancer-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-pharmacokinetics-pk-pharmacodynamics-pd-and-preliminary-efficacy-of-hlx301-a-bispecif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immune-checkpoint-inhibitor-ici-associated-autoimmune-hemolytic-anemia-aiha-on-mortali 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-first-in-human-study-of-ds-2243-an-hla-a02ny-eso-directed-bispecific-t-cell-engager-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-and-out-of-pocket-cost-after-car-t-cell-therapy-in-commercially-insured-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quilt-3076-phase-1-study-of-memory-like-cytokine-enriched-natural-killer-m-cenk-cells-plus-n-803 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-clinicopathological-features-and-outcomes-of-hormone-positive-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mevrometostat-in-combination-with-enzalutamide-in-patients-with-metastatic-castration-resistant-pros 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-sacituzumab-induced-severe-or-febrile-neutropenia-and-g-csf-utilization-and-cost-for-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sup177sup-lu-vipivotide-tetraxetan-psma-vs-cabazitaxel-in-metastatic-castration-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-risk-of-physical-functional-impairment-and-health-care-utilization-in-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-considerate-to-evaluate-patient-experience-in-a-cancer-center-psychometric-and-healthcare-ass 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-benmelstobart-plus-anlotinib-versus-sunitinib-in-advanced-renal-cell-carcinoma-subgroup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-patients-with-primary-refractory-metastatic-renal-cell-carcinoma-receiving-seco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iib-study-of-olaparib-and-astx727-in-brca-12-and-hrd-mutated-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radiographic-ground-glass-nodules-features-and-immune-profiles-in-early-stage-lung-adenocarcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/balancing-tumor-control-and-toxicity-sbrt-strategies-for-ultra-central-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-small-cell-lung-cancer-incidence-and-projections-of-future-burden-through-2050 2026-08-24 monthly 0.7 https://rjrindex.com/articles/importance-of-bulky-lymph-node-involvement-in-locally-advanced-anal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-outcomes-by-inpatient-and-outpatient-infusion-of-axicabtagene-ciloleucel-axi-cel-in-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-burden-and-trend-of-pancreatic-cancer-in-high-income-countries-a-30-year-analysis-of-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-predictors-of-16000-multi-omic-traits-and-associations-with-breast-cancer-survival-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/alk-positive-anaplastic-large-cell-lymphoma-statistics-and-survival-trends 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cd73-on-immune-escape-via-tryptophan-metabolic-reprogramming-in-diffuse-large-b-cell-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/limited-versus-expanded-multigene-germline-genetic-testing-among-adolescents-and-young-adults-aya 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-modalities-and-survival-outcomes-in-patients-with-hepatocellular-carcinoma-with-brain-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/scrna-seq-profiles-to-identify-hes1-associated-with-acth-secreting-tumors-and-the-distinct-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colonoscopy-quality-indicators-for-colorectal-cancer-precursors-sessile-serrated-lesion-and-adenoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/identification-of-germline-hereditary-cancer-syndrome-variants-and-associated-cancers-in-a-healthcar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-individual-and-joint-effects-of-air-pollution-exposure-on-plasma-proteome-among-vulnerable-elder 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-cd4pd-1cxcr6-t-cells-on-the-response-of-immune-checkpoint-inhibitor-therapy-in-brain-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biliary-tract-cancers-a-large-burden-for-little-rhode-island 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-tarlatamab-therapy-for-relapsed-small-cell-lung-cancer-biomarker-identification-and-addr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-haic-or-lenvatinib-combined-with-sintilimab-as-neoadjuvant-therapy-for-high-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-plus-lenvatinib-in-women-with-advanced-or-recurrent-uterine-carcinosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/age-stratified-analysis-of-socioeconomic-disparities-in-non-small-cell-lung-cancer-outcomes-a-natio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-value-of-circulating-tumor-dna-ctdna-detection-by-phased-seq-after-axicabtagene-ciloleu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperthermic-intraperitoneal-chemotherapy-hipec-for-primary-advanced-stage-or-recurrent-ovarian-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-hospital-outcomes-for-uterine-and-ovarian-cancer-patients-a-national-inpatien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-the-efficacy-and-safety-of-donafenib-combined-with-tace-as-adjuvant-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-a-second-primary-cancer-diagnosis-on-health-related-quality-of-life-in-african-america 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oral-oncology-adherence-application-real-world-pilot-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-practice-patterns-and-outcomes-for-metastatic-uveal-melanoma-treated-regionally-versus-system 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hypersensitivity-reactions-to-platinums-systematic-review-of-efficacy-and-safety-of-desensitization 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-gastric-cancer-among-people-with-brca-pathogenic-gene-variants-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-pd-1-inhibitor-tislelizumab-plus-sox-for-locally-advanced-gastric-or-gastro-oesophage 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-single-center-experience-of-pik3ca-and-akt-inhibitors-in-patients-with-hormone-receptor-positive-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-free-survival-in-hr-positive-her2-negative-breast-cancer-cdk46-inhibitors-combination 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meta-analysis-of-the-efficacy-of-cdk46-inhibition-in-the-management-of-metastatic-her2hr-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lymph-node-characteristics-on-clinical-outcomes-in-clinical-n2-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategic-efforts-for-optimal-outcomes-in-patients-with-low-anterior-resection-syndrome-lars-at-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-large-centre-study-of-pathological-and-clinical-characteristics-of-signet-ring-and-mucinous-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spyk04-a-novel-raf-mek-molecular-glue-dose-escalation-de-in-first-in-human-study-for-mapk-pathwa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-phase-1-clinical-trial-of-anti-pd-1-ab-plus-intrahepatic-injection-of-oncolytic-virus-oh2-comb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-lung-cancer-and-cardiovascular-disease-related-mortality-among-older-adul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrated-immune-profiling-approach-for-immuno-oncology-unveiling-biomarkers-and-therapeutic-targe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-update-on-the-results-of-ibi110-anti-lag-3-antibody-plus-sintilimab-anti-pd-1-antibody-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunotherapy-in-gastrointestinal-cancers-with-pre-existing-autoimmune-disorders 2026-08-24 monthly 0.7 https://rjrindex.com/articles/niraparib-plus-pd-1-inhibitor-for-patients-previously-treated-with-immune-checkpoint-inhibitor-for-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-recombinant-interleukin-15-in-combination-with-nivolumab-and-ipilimumab-in-subjects 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sarcopenia-and-postoperative-outcomes-in-patients-with-peritoneal-carcinomatosis-undergoing-cytoredu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-basket-study-to-evaluate-the-tissue-agnostic-efficacy-of-anti-pd1-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-study-of-dzd8586-a-non-covalent-bbb-penetrant-lynbtk-dual-inhibitor-as-monotherapy-in-rel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-manageable-toxicity-of-mogamulizumab-in-a-real-world-north-american-cohort-of-adult-t-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-profiling-to-identify-a-functionally-high-risk-smoldering-multiple-myeloma-patient-population 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-result-of-a-phase-ib-study-efficacy-and-safety-of-fg-m108-plus-gemcitabine-and-nab-pacl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-the-uptake-of-free-cancer-screening-services-in-rural-india-using-machine-learning-tools 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-efficacy-and-mechanism-of-action-of-combined-pan-raf-and-mek-inhibition-in-halting-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multi-cancer-risk-prediction-in-asymptomatic-adults-using-urinary-glycosaminoglycan-profiling 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-phase-ib-dose-expansion-study-to-assess-the-efficacy-of-cd137fap-agonist-bi-765179-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-gut-microbiome-composition-in-the-ibd-crc-pathway-a-retrospective-study-of-428-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-survive-study-standard-surveillance-vs-intensified-liquid-biopsy-based-surveillance-in-early-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-lorlatinib-dose-modifications-on-adverse-event-outcomes-in-the-phase-3-crown-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/able-32-a-randomized-controlled-phase-3b-clinical-trial-of-nadofaragene-firadenovec-vncg-versus-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-guided-adaptive-first-line-chemoimmunotherapy-for-non-small-cell-lung-cancer-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-of-pd-l1-expression-on-live-single-circulating-tumor-cells-with-pd-l1-in-tumor-tissue-as 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-23-study-of-bicycle-toxin-conjugate-zelenectide-pevedotin-bt8009-targeting-nectin-4-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/solti-2201-across-trop2-trial-a-phase-ii-study-to-identify-predictive-biomarkers-of-sacituzumab-gov 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bispecific-innate-cell-engager-ice-afm24-in-combination-with-atezolizumab-in-patients-with-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-and-impact-of-b7-h3-icd276i-expression-across-dise 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparable-efficacy-and-safety-of-taletrectinib-for-advanced-ros1-non-small-cell-lung-cancer-across 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zongertinib-in-her2-altered-breast-cancer-preclinical-activity-and-preliminary-results-from-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combined-prognostic-value-of-post-surgery-circulating-tumor-dna-and-tumor-stroma-ratio-in-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toll-like-receptor-7-tlr7-agonists-and-ox40-agonists-injection-combined-with-sbrt-in-advanced-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-large-language-model-llm-based-clinical-abstraction-of-electronic-health-records-eh 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treating-the-untended-real-world-insights-into-enfortumab-vedotin-plus-pembrolizumab-for-frail-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-time-clinical-validation-of-a-blood-cell-free-mrna-based-geneverify-test-for-screening-and-ear 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utility-of-deep-versatile-classifier-for-accurate-subtyping-of-lung-adenocarcinoma-using-hematoxylin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-profiling-and-survival-in-oncogene-addicted-resected-stage-iiian2-non-small-cell-lung-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-administration-of-car-t-cell-therapy-a-university-of-arizona-cancer-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dynamic-circulating-tumor-dna-driven-risk-adapted-systematic-therapy-in-nasopharyngeal-carcinoma-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-ldh-as-a-prognostic-biomarker-of-early-treatment-failure-in-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-cjrb-101-a-live-biotherapeutic-product-in-combination-with-pembrolizumab-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1b-study-investigating-the-safety-tolerability-and-preliminary-efficacy-of-hx009-in-post-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-report-of-a-single-arm-single-center-retrospective-analysis-investigating-pd-l1-plus-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-prediction-of-claudin-182-expression-and-immune-phenotype-to-guide-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/petosemtamab-mcla-158-with-pembrolizumab-as-first-line-1l-treatment-of-pd-l1-recurrentmetastat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-gender-equity-in-cancer-research-across-north-africa-a-comprehensive-analysis-of-womens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-assessment-of-response-to-chemotherapy-via-ctdna-in-soft-tissue-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-rasolute-302-a-phase-3-multicenter-global-open-label-randomized-study-of-dara 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patritumab-deruxtecan-her3-dxd-in-resistant-iegfri-mutated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-traditional-nlp-methods-and-llm-based-extraction-for-identifying-biomarkers-in-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acr246-a-first-in-next-generation-5t4-adc-as-a-potential-choice-of-treating-5t4-positive-solid-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-molecular-characteristics-of-early-progressors-eps-and-long-term-progression-free-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ideate-pantumor02-a-phase-1b2-study-to-evaluate-the-efficacy-and-safety-of-ifinatamab-deruxtecan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imlunestrant-with-or-without-abemaciclib-in-advanced-breast-cancer-abc-safety-analyses-from-the-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-rapid-progression-on-cdk46-inhibitor-cdki-for-metastatic-hrher2-breast-cancer-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-from-a-phase-ii-study-of-perioperative-disitamab-vedotin-rc48-adc-plus-cadonilimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/imyci-amplification-as-a-prognostic-biomarker-in-osteosarcoma-a-report-fro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-glucagon-like-peptide-1-receptor-agonists-on-morbidity-and-mortality-in-multiple-myeloma-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-real-world-recurrence-in-high-risk-hr-non-muscle-invasive-bladder-cancer-nmibc-treated 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-to-evaluate-the-efficacy-and-safety-of-glsi-100-gp2-gm-csf-in-breast-cancer-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artemide-lung03-a-phase-3-randomized-double-blind-multicenter-global-study-of-rilvegostomig-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/communication-skills-training-program-for-medical-staff-in-cancer-genomic-testing-a-mixed-methods-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-post-surgical-mrd-status-with-neoadjuvant-ctdna-dynamics-genomic-mutations-and-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/myc-amplification-and-protein-expression-as-prognostic-markers-in-pediatric-and-young-adult-osteosar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/maintenance-chemotherapy-in-patients-with-high-risk-rhabdomyosarcoma-long-term-survival-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-activity-of-ebc-129-a-first-in-class-anti-n256-glycosylated-ceacam5-and-ceacam6-antibody 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-patient-characteristics-treatment-patterns-and-clinical-outcomes-of-renal-cell-carc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-enfortumab-vedotin-pembrolizumab-ev-p-based-treatment-toxicity-treatment-discont 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ember-lung-electronic-medical-record-boosting-molecular-testing-in-early-stage-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-hospital-outcomes-of-patients-admitted-with-chronic-obstructive-pulmonary-disease-exacerbation-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-retrospective-study-of-induction-immunochemotherapy-followed-by-definitive-chemoradiotherapy-and-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-mgmt-methylation-on-overall-survival-in-solid-tumors-a-systematic-review-and-meta-analysi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tolerance-to-cd46-inhibitor-therapy-as-first-line-therapy-among-er-patients-with-metastatic-breast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-treatment-and-survival-outcomes-for-early-stage-nsclc-in-veterans-insights-from-cancer-cube 2026-08-24 monthly 0.7 https://rjrindex.com/articles/leveraging-electronic-medical-records-for-early-lung-cancer-diagnosis-an-evaluation-of-the-c-the-si 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inflammatory-bowel-disease-and-risk-of-cancer-a-nationwide-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adjuvant-chemotherapy-outcomes-among-patients-with-stage-ii-early-onset-colon-cancer-in-alberta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-oncologic-outcomes-in-elderly-patients-with-localized-anal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-minimal-comprehensive-somatic-panel-to-aid-clinical-decision-making-in-a-low-cost-setting 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-and-disparities-in-oropharyngeal-cancer-mortality-in-the-united-states-a-retrospective-analy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictors-of-overall-survival-in-patients-with-brain-metastases-from-her2-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insights-into-hpv-mediated-oropharyngeal-squamous-cell-carcinoma-a-northern-nevada-epidemiological 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-safety-and-effectiveness-of-avelumab-in-immune-compromised-ic-and-non-ic-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lung-cancer-mortality-in-brazil-from-2004-to-2023 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outpatient-treatment-related-toxicity-after-hospital-discharge-among-patients-receiving-lifileucel-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/radioimmunotherapy-associated-myeloid-neoplasms-real-world-multicenter-retrospective-study-using-tr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/liposomal-vs-conventional-doxorubicin-as-first-line-therapy-in-advanced-soft-tissue-sarcomas-a-tert 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-gut-microbiota-with-therapy-efficacy-and-prognosis-in-biliary-tract-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-elevated-ca19-9-and-cancer-associated-macrophages-in-blood-with-outcomes-in-pancreati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/siglec15-as-a-potential-therapeutic-target-for-the-treatment-of-fibrosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-pathological-characteristics-of-primary-duodenal-adenocarcinoma-and-the-construction-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/national-trends-in-disability-adjusted-life-years-dalys-of-gastric-cancer-among-elderly-70-years 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-setup-margin-and-biology-tracking-zone-variations-on-dosimetric-plan-quality-and-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-socioeconomic-and-treatment-patterns-in-malignant-brenner-tumors-a-national-cancer-da 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-non-invasive-metabolomic-biomarker-for-detecting-cervical-intraepithelial-neoplasia-and-cervical-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-performance-of-artificial-intelligence-based-computed-tomography-methods-in-detecting-pan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-surgical-intervention-with-30-day-re-admission-and-outcomes-in-patients-hospitalized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/global-cervical-cancer-outcomes-and-national-cancer-system-characteristics 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-donafenib-combined-with-tace-as-adjuvant-therapy-in-patients-with-hepatoc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-anemic-patients-with-early-onset-breast-cancer-an-analysis-of-the-national-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-characteristics-and-their-clinical-significance-in-a-large-cohort-of-biliary-tract-cancers-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-transarterial-radioembolization-in-hepatocellular-carcinoma-patients-with-la 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cervical-cancer-treatment-patterns-amp-outcomes-in-sub-saharan-africa-findings-from-a-multi-insti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-advanced-ovarian-cancer-treated-with-neoadjuvant-chemotherapy-versus-primary-cy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-metastatic-sites-on-response-to-immunotherapy-in-patients-with-advanced-or-recurrent-endom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/germline-genetic-testing-in-patients-with-uterine-serous-carcinoma-at-a-tertiary-academic-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-role-of-a-suspicion-of-cancer-clinic-in-lung-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/empowering-patient-voices-in-oncology-the-role-of-patient-advocacy-in-medical-education-and-researc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impactmf-randomized-open-label-phase-3-trial-of-imetelstat-ime-versus-best-available-therapy-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-characteristics-molecular-landscape-and-survival-outcomes-of-metastatic-pancreatic-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cytoreductive-nephrectomy-for-patients-with-metastatic-non-clear-cell-renal-cell-carcinoma-results 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neooptimize-phase-ii-trial-of-adaptive-switching-of-neoadjuvant-folfirinox-ffx-to-gemcitabinenab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/renal-cancer-mortality-and-disability-worldwide-insights-from-the-global-burden-of-disease-1990-20 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-targeted-therapies-on-overall-survival-in-advanced-malignancy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-in-er-positiveher2-negative-non-metastatic-invasive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-and-disparities-of-covid-19-on-hematological-malignancies-a-database-study-focused-on-hospit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-and-cost-effectiveness-of-a-molecular-biomarker-for-immune-checkpoint-inhibitor-res 2026-08-24 monthly 0.7 https://rjrindex.com/articles/antibody-drug-conjugates-and-pneumonitis-risk-in-breast-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-study-of-171-cases-of-mucinous-ovarian-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/randomized-phase-ii-study-to-evaluate-treatment-with-induction-therapy-with-nivolumab-plus-ipilimuma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/conducting-stoma-free-intersphincteric-resection-for-ultra-low-rectal-cancers-by-selective-delayed-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-circulating-tumor-cells-with-cns-metastatic-patterns-and-survival-outcomes-in-her2-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exposure-to-di-2-ethylhexyl-phthalate-and-hormone-receptor-positive-breast-cancer-incidence 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-effect-of-patient-self-reported-confidence-on-psychosocial-outcomes-in-the-context-of-lymphoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd79b-targeted-antibody-drug-conjugate-adc-shr-a1912-in-combination-with-rituximab-gemcitabine-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-glucagon-like-peptide-1-receptor-agonists-with-cancer-risk-in-obesity-adults-with-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-geographic-and-facility-specific-trends-in-malignant-neoplasms-of-the-bile-duct-mortal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/performance-of-previously-described-polygenic-risk-scores-for-prostate-cancer-in-a-population-with-m 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-clinical-and-molecular-outcomes-of-first-second-and-third-generation-tyrosine-kinase-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-on-treatment-efficacy-and-safety-of-tyrosine-kinase-inhibitors-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/financial-toxicity-and-drivers-of-delayed-care-among-cancer-survivors-across-the-lifespan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/summarizing-utilization-of-integrative-oncology-assessments-within-inpatient-and-outpatient-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-worker-driven-distress-screening-among-gynecologic-oncology-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-radiation-pneumonitis-mortality-risk-among-patients-with-underlying-lung-disease 2026-08-24 monthly 0.7 https://rjrindex.com/articles/climate-change-and-cancer-an-ecological-evaluation-of-climate-risks-for-cancer-survivors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/healthcare-disparities-in-hepatocellular-carcinoma-mortality-across-different-racial-groups-in-the-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/social-needs-and-systemic-inflammation-associated-with-cancer-survival-among-a-historically-marginal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dedicated-resources-for-veteran-clinical-trial-participation-the-prostate-cancer-analysis-for-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ethnic-and-socioeconomic-disparities-in-survival-outcomes-among-patients-under-65-years-with-intrahe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-economic-impact-of-active-e-health-support-in-patients-with-advanced-and-metastatic-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcomes-epro-in-patients-with-advanced-melanoma-receiving-immune-chec 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pregnancy-during-cancer-treatment-a-population-based-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/developing-a-simple-outpatient-prognostic-model-for-prediction-of-survival-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-mortality-from-endocrine-neoplasms-in-the-united-states-a-cdc-wonder-analysis-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ib-study-of-a-pooled-synthetic-long-peptide-mutant-kras-vaccine-combined-with-balstilimabbo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pd-1pd-l1-inhibitors-as-second-line-therapy-for-advanced-unresected-esophageal-squamous-cell-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-yijing-buqi-yangxue-prescription-on-the-proliferation-and-related-signal-transduction-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-digital-intervention-to-enhance-engagement-with-oral-oncolytic-treatments-and-assess-patient-exper 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-the-hpv-ebv-and-ttv-viral-rna-in-the-plasma-of-patients-with-solid-and-hematologic-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-characterization-of-interleukin-enhanced-factor-2-ilf2-in-triple-negative-breast-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sars-cov-2-mrna-bnt162b2-vaccination-on-survival-outcomes-in-metastatic-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/anti-programmed-death-1-inhibitors-and-nimotuzumab-in-combination-with-induction-chemotherapy-for-lo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-metabolite-profiling-of-ffpe-tissue-to-analyze-metabolic-changes-in-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-biomarkers-for-immune-related-adverse-events-pd-l1-and-somatic-mutations 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tumor-informed-ctdna-for-recurrence-and-survival-prediction-in-hpv-independent-head-and-neck-squamou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-registry-for-acral-melanoma-in-lebanon-a-12-year-single-center-experience-in-the-mena 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-young-onset-colorectal-cancer-vs-late-onset-colorectal-cancer-patients-on-phase-1-matche 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-treatment-patterns-and-patient-characteristics-in-the-advanced-and-metastatic-esophageal-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/belantamab-mafodotin-pomalidomide-dexamethasone-bpd-vs-daratumumab-bortezomib-dexamethason 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-signals-of-inflation-reduction-act-impact-on-small-molecule-versus-biologic-post-approval-onco 2026-08-24 monthly 0.7 https://rjrindex.com/articles/monitoring-concordance-with-evidence-based-guidelines-in-the-treatment-of-stage-i-to-iiia-lung-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-exosome-derived-lncrna-on-mal-supsup-ctl-apoptosis-in-remode 2026-08-24 monthly 0.7 https://rjrindex.com/articles/delays-in-cancer-treatment-initiation-in-brazil-a-nationwide-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-care-resource-utilization-hcru-and-costs-in-insured-patients-with-advanced-lung-cancer-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ispopi-mutations-in-veterans-with-metastatic-castration-resistant-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-metastatic-castration-resistant-prostate-cancer-clinical-trials-between-2005-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acute-ischemic-stroke-in-prostate-cancer-patients-epidemiology-outcomes-and-key-insights-from-a-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breast-cancer-in-the-rio-grande-valley-telemedicine-as-a-solution-in-the-disruption-in-breast-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/continuous-financial-toxicity-screening-in-community-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-race-on-the-association-between-structural-racism-and-the-quality-of-non-small-cell-lu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-obesity-and-metabolic-syndrome-on-survival-in-acute-promyelocytic-leukemia-a-real-world-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mapping-policy-effects-the-influence-of-medicaid-expansion-on-geospatial-hotspots-of-incidence-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-diversity-examining-the-feasibility-of-conducting-oncology-trials-in-south-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-survival-among-younger-breast-cancer-patients-a-seer-database-analysis-2000-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-immigration-status-on-survival-amongst-early-stage-1amp2-her2-positive-and-triple-nega 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-person-cancer-care-analyzing-patient-needs-and-service-utilization-at-inova-schar-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-precision-oncology-in-soft-tissue-sarcomas-the-role-of-itrac-in-metastatic-risk-stratific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vitro-profiling-of-idrx-42-against-secondary-and-tertiary-mutations-apal-found-in-tki-resistan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multicenter-randomized-global-phase-3-study-to-assess-the-efficacy-and-safety-of-intratumoral-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-anti-egfr-and-anti-vegf-antibodies-on-survival-in-braf-supv600esup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-to-lymphocyte-ratio-nlr-as-an-independent-prognostic-marker-in-mutyh-associated-colore 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colorectal-cancer-in-young-adults-what-social-behavior-factors-may-be-responsible 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicogenomic-analysis-of-iegfri-mutant-lung-cancers-for-identificati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-between-extended-and-standard-infusion-in-patients-with-chemotherapy-induced-febrile-neut 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-application-of-a-novel-multidisciplinary-pharmacovigilance-pv-clinic-in-patients-pts-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-ttmv-hpv-dna-kinetics-in-induction-chemotherapy-in-hpv-positive-head-and-neck-sq 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-profile-of-pembrolizumab-for-primary-pulmonary-nut-carcinoma-a-systematic-review-and-meta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-transcriptomic-profiling-from-over-300-leiomyosarcoma-samples 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantifying-the-clinical-impact-of-tissue-reflex-testing-for-liquid-biopsy-iesr1i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pulmonary-toxicities-in-patients-pts-with-metastatic-breast-cancer-mbc-treated-with-trastuzumab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-ml-model-predictive-for-chemotherapy-toxicity-and-termination-in-a-real-world-com 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-incidence-of-thrombosis-and-cardiovascular-adverse-events-associated-with-immune-checkpoi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nf1-and-non-nf1-associated-malignant-peripheral-nerve-sheath-tumors-mpnst-the-university-of-texa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-data-analysis-of-anti-her2-therapy-induced-cardiotoxicity-in-breast-cancer-patients-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-and-effectiveness-of-patient-retention-strategies-in-cancer-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-to-lymphocyte-ratio-as-a-clinical-biomarker-for-immune-checkpoint-inhibitor-response-in-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-study-of-tislelizumab-combined-with-concurrent-chemoradiotherapy-in-the-trea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-value-of-circulating-tumor-dna-detection-for-long-term-survival-in-patients-with-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/t-cell-effector-cytokine-signature-as-predictor-of-survival-and-toxicity-in-metastatic-nsclc-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroendocrine-marker-expression-in-dendritic-cell-sarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/acoustic-biomarkers-and-ai-transforming-nsclc-detection-and-personalized-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-non-invasive-machine-learning-model-for-predicting-tertiary-lymphoid-structures-and-treatmen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plp-powered-exosomal-therapeutics-redefining-immune-activation-in-therapy-resistant-tumor-microenvi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-niraparib-in-men-with-dna-repair-gene-deficient-clinically-localized-prostate-cancer-cl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/integrative-clinico-genomic-evaluation-of-the-human-epidermal-growth-factor-receptor-2-her2-in-uro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/camrelizumab-plus-with-nimotuzumab-in-the-second-line-treatment-of-advanced-esophageal-squamous-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-role-of-hla-supertypes-in-pmmr-mcrc-patients-receiving-folfoxiribev-ate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitor-associated-myocarditis-incidence-risk-factors-and-clinical-outcomes-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/linvoseltamab-linvo-carfilzomib-cfz-in-patients-pts-with-relapsedrefractory-multiple-myelom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hippocampal-avoidance-whole-brain-radiotherapy-with-dose-escalation-on-metastases-a-prospective-ran 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-survival-outcomes-in-sarcomatoid-hepatocellular-carcinomas-in-the-era-of-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dual-immunotherapy-with-nivolumab-and-ipilimumab-for-metastatic-melanoma-real-world-outcomes-from-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pembrolizumab-and-lenvatinib-in-the-treatment-of-recurrent-platinum-resistant-ovarian-carcinoma-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-of-poor-risk-non-seminomatous-germ-cell-tumors-nsgct-adapted-by-tumor-marker-decline-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncoshare-lung-novel-three-way-linkage-of-neighboring-academic-and-community-medical-centers-to-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-cell-leukemia-updates-on-demographics-and-prognostication 2026-08-24 monthly 0.7 https://rjrindex.com/articles/single-arm-prospective-study-evaluating-the-relationship-of-ctdna-molecular-complete-response-mcr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunosarc2-cohort-7a-a-spanish-sarcoma-group-geis-phase-ib-trial-of-epirubicin-and-ifosfamide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-serplulimab-in-combination-with-chemotherapy-for-locally-advanced-gastric-or-gastro-esop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/music-therapy-versus-cognitive-behavioral-therapy-for-anxiety-in-cancer-survivors-a-telehealth-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-to-evaluate-the-safety-and-efficacy-of-bb-1701-in-subjects-with-her2-expression-loc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-based-mrd-detection-in-unresectable-nsclc-undergoing-curatively-intended-chemoradiotherapy-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/response-to-induction-chemotherapy-and-identification-of-tumor-heterogeneity-through-a-comprehensive 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-ctdna-in-patients-with-muscle-invasive-bladder-cancer-mibc-who-received-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-precision-medicine-trial-leveraging-tissue-and-blood-based-tumor-genomics-to-optimize-treatment-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-tislelizumab-combined-with-disitamab-vedotin-rc48-for-patients-with-her-2-expressing-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1b2-study-evaluating-telisotuzumab-adizutecan-abbv-400-temab-a-in-combination-with-budigal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-camrelizumab-plus-chemotherapy-in-patients-with-advanced-non-squamous-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/eortc-2129-bcg-elacestrant-for-treating-erher2-breast-cancer-patients-with-ctdna-relapse-treat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-active-chromatin-cell-free-dna-cfdnaac-assay-for-early-detection-of-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-ibii-study-to-evaluate-the-safety-and-efficacy-of-atezolizumab-plus-beva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-analysis-of-affinity-trial-quantification-of-tumor-specific-antibodies-and-immune-cell-act 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-based-radiomics-for-prediction-of-isocitrate-dehydrogenase-subtype-in-glioblastoma-multiforme-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-fusion-of-radiomic-pathomic-and-clinical-biomarkers-on-multi-scale-tumor-biology-and-os 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onkoras-101-a-phase-1a1b-open-label-study-evaluating-the-safety-tolerability-pharmacokinetics-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/soho-02-phase-iii-trial-of-bay-2927088-in-patients-with-locally-advanced-or-metastatic-nsclc-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinicopathological-features-and-risk-factors-of-type-1-and-type-2-endometrial-cancer-a-retrospecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-patterns-in-hrher2-metastatic-breast-cancer-mbc-with-co-occurring-ipik3 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preclinical-evaluation-of-the-efficacy-of-anti-pvr-antibody-drug-conjugates-combined-with-anti-pd-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-elinzanetant-for-vasomotor-symptoms-associated-with-adjuvant-endocrine-therap 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-study-of-ori-c101-an-armored-gpc3-directed-car-t-in-patients-with-advanced-hepatocellular 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunoprofiling-a-prospective-multi-cohort-study-to-characterize-circulating-immune-response-in-adv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-line-immunotherapy-with-or-without-chemotherapy-versus-braf-plus-mek-inhibitors-for-patients-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/results-of-the-prospective-randomized-controlled-trial-vog-01-neoadjuvant-endocrine-therapy-ribocic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nugena-nurse-led-genetic-counselling-and-awareness-a-proof-of-concept-to-implementation-of-geneti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-mortality-rates-in-the-united-states-population-suffering-from-hodgkins-versus-non-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-radiological-tumor-burden-to-sub-stratify-imdc-risk-groups-in-metastatic-renal-cell-carcino 2026-08-24 monthly 0.7 https://rjrindex.com/articles/adverse-events-of-interest-aeis-with-zanubrutinib-vs-fixed-duration-combination-of-venetoclax-ob 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-analysis-of-the-tumor-immune-microenvironment-in-lung-squamous-cell-carcinomas-with-and-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-stamp-seq-to-enable-spatial-transcriptomics-through-single-nucleus-in-situ-tagging-and-explor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-targeted-petct-with-sup68sup-ga-my6349-for-the-diagnosis-of-prim 2026-08-24 monthly 0.7 https://rjrindex.com/articles/race-associated-clinicogenomic-correlates-of-outcomes-to-immune-checkpoint-inhibitors-alone-or-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-different-pd-1-inhibitors-combined-with-chemotherapy-in-locally-advanced-head 2026-08-24 monthly 0.7 https://rjrindex.com/articles/induction-chemotherapy-ic-followed-by-concomitant-radiotherapy-and-weekly-cisplatin-ccrt-versus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-hoc-analysis-of-rashes-reported-in-patients-pts-with-ibrafi-alt 2026-08-24 monthly 0.7 https://rjrindex.com/articles/drug-eluting-beads-loaded-with-irinotecan-transarterial-chemoembolization-debiri-tace-combined-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-immune-checkpoint-inhibitors-and-concurrent-radiation-therapy-for-the-treatment-of-ext 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-dynamic-changes-in-tumor-infiltrating-lymphocytes-til-after-neoadjuvant-admini 2026-08-24 monthly 0.7 https://rjrindex.com/articles/irinotecan-temozolomide-and-naxitamab-plus-gm-csf-hits-and-naxitamab-plus-gm-csf-and-ifosfamide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-and-predictive-impact-of-the-baseline-systemic-proteome-in-patients-with-ir 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neutrophil-to-lymphocyte-ratio-as-a-predictor-of-response-and-toxicity-in-t-cell-engager-therapy-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-targeted-petct-with-sup68sup-ga-my6349-for-detecting-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/strategies-to-achieve-racial-equity-in-cardio-oncology-care-for-women-with-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-early-onset-colorectal-cancer-implications-for-research-and-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-based-next-generation-sequencing-in-advanced-non-small-cell-lung-cancer-nsclc-significance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iii-study-to-evaluate-the-feasibility-and-efficacy-of-sequential-abemaciclib-and-gemcitabine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalized-tumor-informed-circulating-tumor-dna-analysis-in-monitoring-recurrence-following-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/baseline-circulating-growth-differentiation-factor-15-and-the-cancer-phenotype-in-the-proacc-1-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/do-all-patients-with-primary-retroperitoneal-sarcoma-benefit-from-resection 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-molecular-biomarker-for-longitudinal-monitoring-of-therapeutic-efficacy-in-a-real-world-cohort-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-fine-particulate-matter-exposure-on-breast-cancer-mortality-a-county-level-analysis-in-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-of-developing-multisystem-immunotherapy-related-adverse-events-among-patients-with-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-smoking-on-immunotherapy-outcomes-in-cancer-a-multi-center-retrospective-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-outcomes-of-metastatic-prostate-cancer-hospitalizations-2008-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-of-patients-with-lung-cancer-at-a-large-safety-net-health-system-implications-for-h 2026-08-24 monthly 0.7 https://rjrindex.com/articles/21-gene-expression-assay-in-postpartum-vs-non-postpartum-breast-cancer-and-correlation-with-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-adjuvant-endocrine-therapy-on-outcomes-in-estrogen-receptor-low-positive-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bci-biomarker-performance-in-premenopausal-women-with-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-zimberelimab-and-cetuximab-plus-nab-paclitaxel-and-cisplatin-neo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-recist-choi-modified-choi-mchoi-and-viable-tumor-volume-vtv-in-predicting-clinical-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-survival-and-treatment-efficacy-in-dmmrmsi-h-rectal-cancer-a-real-world-cohort-from-seve 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-trial-to-evaluate-the-efficacy-and-safety-of-wztl-002-a-third-generation-anti-cd19-car-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-and-prognostic-implications-of-the-tcr-repertoire-in-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-palliative-care-use-and-clinical-outcomes-among-hospitalized-lung-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuro-oncology-anywhere-preliminary-results-from-a-decentralized-clinical-trial-aimed-at-improving 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improved-survival-with-sodium-glucose-cotransporter-2-inhibitors-and-immune-checkpoint-inhibitors-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-metabolic-connectivity-in-patients-with-multiple-myeloma-receiving-bcma-car-t-cell-the 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-factors-for-cancer-and-screening-tests-in-the-population-of-the-pantanal-a-rural-region-of-bra 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-based-sequential-analysis-for-optimal-selection-between-ird-and-krd-regimen-in-mult 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advanced-ensemble-stacking-model-employing-cfdna-fragmentation-for-early-detection-of-esophageal-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-association-and-impact-of-radiographic-pathological-and-spirometric-emphysema-on-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hivreo-recommendations-on-the-management-of-people-living-with-hiv-and-cancer-plwhc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-in-target-discovery-cure-ai-prediction-of-tigit-and-pd-l1-as-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-lung-cancer-screening-using-low-dose-computed-tomography-ldct-scan-in-a-community-hospi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/inpatient-characteristics-and-outcomes-among-adolescent-and-young-adult-patients-with-metastatic-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mortality-trends-in-multiple-myeloma-and-cardiovascular-disease-in-the-us-1999-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/quantitative-parameters-on-whole-body-diffusion-weighted-mri-wb-dwmri-and-psma-petct-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/long-term-outcomes-in-triple-negative-breast-cancers-tnbc-treated-with-talimogene-laherparepvec-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-pre-transplant-biological-aging-markers-and-clinical-outcomes-in-allogeneic-hema 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mri-based-radiomic-signature-and-its-association-with-genomic-complexity-in-breast-tumor-heterogenei 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-validation-of-a-novel-multimodal-ai-prognostic-tool-integrating-digital-pathology-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-engagement-in-accelerating-care-level-activation-of-precision-medicine-with-patient-educatio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cost-effectiveness-of-her2neu-655-genotyping-in-managing-trastuzumab-induced-cardiotoxicity-risk-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-side-effects-of-targeted-therapies-high-throughput-association-studies-leveraging-the-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/enabling-national-identification-of-lung-cancer-screening-eligibility-with-large-language-models 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-chemotherapy-use-and-clinical-outcomes-in-young-brca-carriers-with-t1n0-breast-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-deep-learning-ct-response-assessment-and-interpretable-components-with-overall-surviv 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-in-motion-how-fitbit-data-reflects-patients-with-cancers-functional-status-in-the-all-of-u 2026-08-24 monthly 0.7 https://rjrindex.com/articles/treatment-related-neutropenia-as-a-predictor-of-response-to-adjuvant-palbociclib-in-the-pallas-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-of-a-novel-nomogram-to-predict-clinically-significant-prostate-cancer-using-exodx-urinar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-demographics-and-outcomes-in-young-versus-average-onset-hospitalized-gastroi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-pump-inhibitors-and-the-risk-of-adverse-renal-events-and-all-cause-mortality-in-cancer-patien 2026-08-24 monthly 0.7 https://rjrindex.com/articles/validation-of-real-world-event-free-survival-rwefs-in-early-stage-triple-negative-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-immunotherapy-for-advanced-gastric-and-gastroesophageal-junction-cancer-a-modelling-cost 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-multi-omic-biosignature-for-identification-of-early-stage-invasive-breast-cancer-patients-who 2026-08-24 monthly 0.7 https://rjrindex.com/articles/toripalimab-with-chemoradiotherapy-followed-by-toripalimab-maintenance-therapy-for-newly-diagnosed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-bedroom-renewed-air-as-anti-inflammatory-adjuvant-therapy-in-cancer-survivors-breaths-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/potent-antitumor-activity-of-the-kras-supg12dsup-inhibitor-mrtx1133-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/optimizing-treatment-sequencing-in-hepatocellular-carcinoma-impact-of-radioembolization-timing-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-real-world-analysis-of-the-effectiveness-of-pembrolizumab-by-type-of-associated-treatment-in-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-for-smokers-with-early-onset-breast-cancer-an-analysis-of-the-national-inpatient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-comparative-study-of-the-real-world-safety-and-effectiveness-of-metronomic-cyclophosphamide-and-be 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-pembrolizumab-plus-olaparib-for-the-treatment-of-patients-with-persistentrecurr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/duration-and-de-escalation-of-folfirinox-as-first-line-chemotherapy-in-advanced-pancreatic-adenocarc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analyzing-trends-in-vulvovaginal-cancer-mortality-in-the-united-states-from-1999-to-2020 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-serous-carcinoma-subgroup-in-frusica-1-fruquintinib-plus-sintilimab-in-treated-advanced 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-proteo-metabolic-panel-for-detection-of-asymptomatic-ovarian-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-gender-responsive-cancer-control-a-mixed-methods-evaluation-of-the-leadership-program-for 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-of-envafolimab-combined-with-capecitabine-and-lenvatinib-as-postoperative-adjuvant-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-and-mechanism-of-stf-31-combined-with-cisplatin-in-overcoming-platinum-resistance-in-ovarian 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-safety-and-efficacy-of-selective-internal-radiation-therapy-for-hepatocellular-carcinoma-a-retr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/electronic-patient-reported-outcomes-epro-based-alerts-deployed-in-clinical-practice-to-inform-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/insurance-disparities-among-subgroups-of-hispanic-americans-with-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/breaking-down-barriers-role-of-artificial-intelligence-in-patient-friendly-breast-cancer-education 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparing-the-use-and-quality-of-palliative-and-end-of-life-care-between-asian-and-non-asian-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/envafolimab-monotherapy-or-combination-therapy-in-elderly-patients-with-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-analysis-of-immunohistochemistry-and-imaging-mass-cytometry-technologies-for-detection-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comprehensive-analysis-of-nsaids-use-and-oncological-outcomes-in-non-small-cell-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exclusion-of-people-from-oncology-clinical-trials-based-on-functional-status-and-other-criteria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-genetically-engineered-isalmonella-typhimuriumi-secreting-con 2026-08-24 monthly 0.7 https://rjrindex.com/articles/recurrence-rates-after-anti-pd1-discontinuation-for-advanced-melanoma-a-systematic-review-and-singl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/spatial-profiling-of-solid-tumor-microenvironment-using-imaging-mass-cytometry-with-high-plex-panels 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-classification-of-uncertain-histologies-based-on-cfdna-fragmentomic-analysis-in-patients-with-un 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biomarker-changes-and-its-prognostic-significance-after-chemotherapy-in-patients-with-de-novo-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-immune-checkpoint-inhibitors-in-patients-with-unresectable-metastatic-colon-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-genetic-role-of-skin-gut-microbial-axis-in-pan-cancer-development 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-transcatheter-arterial-infusion-of-immune-checkpoint-inhibitors-in-locoregion 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combining-machine-learning-with-the-immunohistochemical-expression-of-ambra1-and-loricrin-to-identif 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-clinical-outcomes-of-patients-with-braf-mutated-melanoma-with-or-without-brain-metastases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-gastrointestinal-stromal-tumors-treated-with-imatinib-and-sunitinib-in-nep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-safety-for-bone-marrow-protection-of-trilaciclib-for-patients-with-locally-advanced-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/regional-trends-in-incidence-and-prevalence-of-pancreatic-cancer-among-older-adults-70-a-30-year 2026-08-24 monthly 0.7 https://rjrindex.com/articles/micro-mosaicism-of-ibrafi-v600e-oncogene-in-normal-skin-samples-of-pati 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burnout-professional-fulfillment-and-associated-factors-in-academic-oncology-physicians 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-professional-cancer-societies-in-spreading-awareness-about-oncology-to-undergr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-for-patients-with-congenital-hepatoblastoma-have-they-changed-since-2013 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-prevalence-of-coronary-artery-calcification-among-patients-undergoing-lung-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/descriptive-epidemiology-of-waldenstrom-macroglobulinemia-wm-demographics-outcomes-and-predicto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-treated-for-monomorphic-b-cell-post-transplant-lymphoproliferative-disorder-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-year-impact-of-a-large-scale-pilot-multimodal-personalized-early-cancer-detection-and-prevention 2026-08-24 monthly 0.7 https://rjrindex.com/articles/combination-of-mitoxantrone-hydrochloride-liposome-with-cyclophosphamide-vincristine-and-prednison 2026-08-24 monthly 0.7 https://rjrindex.com/articles/escalating-impact-of-alcohol-related-cancer-mortality-in-the-us-a-call-for-action 2026-08-24 monthly 0.7 https://rjrindex.com/articles/large-scale-clinical-validation-of-a-blood-based-multi-cancer-early-detection-test-across-differen 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-of-a-multidomain-mhealth-based-intervention-in-enhancing-recovery-and-quality-of-life 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-of-patients-with-bladder-cancer-and-lymph-node-metastases-analysis-based-on-a-lar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-sintilimab-versus-pembrolizumab-in-the-treatment-of-advanced-or-recurrent-ped 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-interim-analysis-of-phase-iii-study-on-neoadjuvant-chemotherapy-versus-perioperative-toripalimab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-evidence-of-fruquintinib-fruq-efficacy-after-regorafenib-rego-and-trifluridine-tipira 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-the-tumor-microenvironment-and-neoadjuvant-therapy-response-in-her2-positive-breast-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/post-hoc-analysis-evaluating-selinexor-maintenance-therapy-in-patients-with-itp53i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cardiotoxicity-in-early-breast-cancer-risk-factors-and-predictors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comorbidity-burden-and-risk-factors-rfs-for-peripheral-neuropathy-pn-and-their-prevalence-in-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/should-toxicity-be-taken-into-account-in-determining-chemotherapy-backbone-in-her2-positive-her2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-landscape-of-chromosomal-instability-in-uterine-leiomyosarcoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efbemalenograstim-alfa-for-primary-prophylaxis-of-chemotherapy-induced-neutropenia-in-patients-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-adjuvant-immunotherapy-after-neoadjuvant-immunotherapy-combined-with-chem 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-envafolimab-plus-carboplatin-and-etoposide-as-first-line-treatment-for-extens 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-variations-survival-patterns-and-mortality-determinants-in-small-cell-lung-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/synkir-car-t-cell-advanced-research-star-101-phase-1-clinical-trial-for-patients-with-advanced-mes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-with-fruquintinib-versus-placebo-after-adjusting-for-subsequent-anticancer-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiologic-trends-in-colorectal-cancer-age-related-variations-and-site-specific-patterns-over-tw 2026-08-24 monthly 0.7 https://rjrindex.com/articles/codon-167-missense-mutations-in-von-hippel-lindau-syndrome-genotype-phenotype-correlations-in-a-pop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-preoperative-management-of-patients-with-giant-cell-tumors-in-limb-bones-using-denosumab-therapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-intestinal-exfoliome-and-prevotellaceae-with-toxicity-and-clinical-outcome-during-imm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ivonescimab-pd-1vegf-bispecific-antibody-combined-with-haic-for-first-line-treatment-of-unresecta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/consolidative-camrelizumab-following-definitive-concurrent-chemoradiotherapy-with-involved-field-irr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-significance-of-her2-heterogeneity-in-early-stage-and-locally-advanced-her2-positive-brea 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-between-glycemic-index-and-glycemic-load-of-the-diet-insulin-and-breast-cancer-a-case 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characteristics-and-predictors-of-chronic-immune-related-adverse-events-iraes-following-anti-pd-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-esym-symptom-monitoring-program-on-nurse-telephone-encounters-across-six-cancer-center 2026-08-24 monthly 0.7 https://rjrindex.com/articles/initial-experience-of-preoperative-gemcitabine-and-cisplatin-plus-durvalumab-followed-by-resection-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-efficacy-and-safety-of-biweekly-gemcitabine-and-docetaxel-gemdoc-in-heavily 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-hematopoietic-stem-cell-transplantation-in-t-cell-acute-lymphoblastic-leukemia-adults-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/egl-121-a-first-in-human-phase-12-trial-of-egl-001-in-adult-patients-with-selected-advanced-andor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/psa-and-alkaline-phosphatase-changes-in-the-eortc-1333-peace-3-study-evaluating-the-addition-of-six 2026-08-24 monthly 0.7 https://rjrindex.com/articles/detecting-ctdna-using-personalized-structural-variants-to-forecast-recurrence-in-localized-soft-tiss 2026-08-24 monthly 0.7 https://rjrindex.com/articles/allogeneic-stem-cell-transplantation-related-outcomes-in-myelodysplastic-syndromes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/zanzalintinib-zanza-nivolumab-nivo-relatlimab-rela-in-patients-pts-with-previously-untre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cobra-assessment-of-the-efficacy-of-sup64sup-cu-sar-bispsma-using-hist 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-genetic-characteristics-of-soft-tissue-sarcomas-associated-with-the-development-of-chemoth 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-potential-of-multi-cancer-early-detection-screening-in-reducing-cancer-incidence-and-mortality-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/analysis-of-evidence-in-nccn-harmonized-guidelines-for-sub-saharan-africa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-colorectal-cancer-patient-response-to-neoadjuvant-chemotherapy-using-the-microorganospher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-response-to-durvalumab-and-olaparib-in-mtnbc-using-a-novel-pd-l1-expression-biomarker-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-and-safety-profile-of-adagrasib-in-kras-g12c-mutated-solid-tumors-a-single-arm-me 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-social-determinants-of-health-sdoh-and-outcomes-of-early-onset-colorectal-cancer-eo-cr 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sintilimab-anti-pd-1-plus-ifosfamide-carboplatin-and-etoposide-ice-in-second-line-classical-ho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/seasonal-impact-of-anti-pd-1-treatment-initiation-in-non-small-cell-lung-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/procedure-considerations-for-image-guided-intratumoral-immunotherapy-a-retrospective-study-of-357-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-tumor-burden-on-outcomes-after-immune-versus-conventional-therapies 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-novel-application-of-deep-learning-dl-based-mri-with-liquid-biomarkers-for-immune-effector-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/biosafety-analysis-from-the-skin-cancer-cohorts-in-the-ignyte-clinical-trial-of-rp1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/using-large-language-models-to-assess-adherence-to-asco-patient-oncologist-communication-standards 2026-08-24 monthly 0.7 https://rjrindex.com/articles/methotrexate-doxorubicin-and-cisplatin-versus-methotrexate-doxorubicin-and-cisplatin-ifosfamid 2026-08-24 monthly 0.7 https://rjrindex.com/articles/amivantamab-plus-chemotherapy-vs-chemotherapy-in-iegfri-mutant-advance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessment-of-psma-petct-derived-predictive-markers-for-sup177sup-lu-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-3-randomized-double-blind-placebo-controlled-study-to-assess-the-efficacy-and-safety-of-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impower010-genomic-profiling-and-clinical-outcomes-with-adjuvant-atezolizumab-in-early-stage-non-sm 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-from-the-dose-escalation-stage-of-a-phase-i-trial-of-an-anti-ccr8-antibody-in-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-of-sunitinib-plus-nivolumab-in-extraskeletal-myxoid-chondrosarcoma-results-from-the-geis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/endocrine-therapy-omission-in-estrogen-receptor-low-1-10-early-stage-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-pemetrexed-and-pembrolizumab-in-patients-pts-with-recurrent-andor-metastatic-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperthermic-intraperitoneal-chemotherapy-combined-with-cytoreductive-surgery-versus-cytoreductive-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-guided-adjuvant-chemotherapy-escalation-in-stage-iii-colon-cancer-primary-analysis-of-the-ctd 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trop2-overexpression-as-predictor-of-outcome-in-patients-with-early-triple-negative-breast-cancer-e 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-surgical-resection-in-early-onset-colorectal-cancer-patients-with-liver-limited-diseas 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-i-dose-escalation-trial-of-stx-001-an-lnp-encapsulated-self-replicating-mrna-expressing-il-12 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-benefit-of-cytoreductive-surgery-during-imatinib-im-therapy-in-patients-with-metastatic-gastro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/testing-and-treatment-patterns-in-ikrasi-mutant-mnsclc-results-from-th 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-patients-diagnosed-with-cancer-in-the-inpatient-and-outpatient-settings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hexagon-hn-phase-23-randomized-study-of-the-hexavalent-ox40-agonist-inbrx-106-in-combination-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-the-lymphovascular-invasion-on-the-prognosis-in-pt1-2n0-early-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparities-in-major-adverse-cardiovascular-and-cerebrovascular-events-outcomes-among-gastric 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-features-and-intratumor-microbiome-in-surgically-resected-pancreatic-head-body-and-tail 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-artificial-intelligence-powered-spatial-analysis-of-tumor-microenvironment-to-predict-the-pro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-tumor-extracellular-matrix-density-with-recurrence-in-invasive-lobular-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-curative-surgery-and-outcome-in-a-multicenter-randomized-phase-iii-trial-comparing-conver 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-a-letter-of-condolence-proposing-a-post-mortem-consultation-to-the-relatives-of-cancer-pat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-trastuzumab-deruxtecan-in-gastrointestinal-malignancies-a-systemic-review-an 2026-08-24 monthly 0.7 https://rjrindex.com/articles/survival-outcomes-in-pancreatic-cancer-a-single-center-retrospective-study-in-a-large-healthcare-sy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-analysis-of-overall-survival-in-patients-lost-to-follow-up-after-incidental-neoplasm-f 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-i-clinical-trial-of-abp1019a-monotherapy-in-patients-with-advanced-malignant-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-radionuclide-therapy-on-survival-outcomes-for-de-novo-metastatic-gastroenteropancreatic-ne 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-an-in-silico-clinical-trial-intelligence-solution-to-predict-outcomes-of-tinengotinib-a-pote 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-patients-with-stage-iiiiia-urothelial-bladder-cancer-treated-with-systemic-therapy-a-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analyses-to-evaluate-the-role-of-tigit-as-a-target-in-first-line-1l-gastric-gastroesop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/failure-patterns-and-the-value-of-postoperative-adjuvant-radiotherapy-in-esophageal-squamous-cell-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-of-botensilimab-and-agen1423-an-anti-cd73-tgfv-trap-bifunctional-antibody-with-or 2026-08-24 monthly 0.7 https://rjrindex.com/articles/de-escalation-of-axillary-surgery-in-breast-cancer-patients-with-1-2-positive-sentinel-nodes-after-n 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-features-and-occurrence-of-other-cancers-in-patients-with-chronic-lymphocytic-leukemia-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-nations-uneven-battle-trends-and-regional-disparities-in-cancer-mortality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-future-is-here-now-use-of-proteomic-testing-in-pulmonary-nodule-management-in-an-underserved-po 2026-08-24 monthly 0.7 https://rjrindex.com/articles/tigos-ls-an-open-label-randomized-study-of-bms-986489-vs-durvalumab-as-consolidation-therapy-follo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-sodium-glucose-co-transporter-2-inhibitors-with-cardiac-outcomes-and-mortality-in-can 2026-08-24 monthly 0.7 https://rjrindex.com/articles/application-of-n-terminal-telopeptide-of-type-i-collagen-in-the-evaluation-of-bone-metastasis-degree 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemoradiotherapy-combined-with-tislelizumab-for-locally-advanced-rectal-cancer-a-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-differences-in-the-association-between-agent-orange-exposure-and-the-progression-of-monoclona 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dlbcl-associated-pim1-mutation-and-its-impact-on-anxa2-localization-and-lymphomagenesis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burden-of-pediatric-cns-malignancies-across-204-countries-from-1990-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-iiia-dose-finding-study-of-triplet-regimen-of-relatlimab-rela-ipilimumab-ipi-and-nivolu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sensitivity-of-age-and-family-history-fh-criteria-for-determining-pancreatic-cancer-pc-surveilla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/estimated-prevalence-of-pathogenic-variants-in-patients-with-breast-colon-andor-endometrial-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/digital-profiling-of-tumor-derived-extracellular-vesicle-rna-a-sensitive-approach-for-early-detecti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immune-checkpoint-inhibitors-in-lung-cancer-a-retrospective-cohort-analysis-of-cardiovascular-safet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/perfume-trial-phase-ii-trial-of-binimetinib-in-patients-with-ibrafi-fu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-we-casting-the-net-wide-enough-applying-the-proposed-lung-cancer-screening-criteria-in-single-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluation-of-surrogate-endpoints-in-muscle-invasive-bladder-cancer-mibc-a-systematic-review-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cascade-conversations-empowering-cancer-genetic-testing-through-cascade-chatbots 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-regional-trends-in-cardiovascular-disease-and-hodgkin-lymphoma-related-mortality-in 2026-08-24 monthly 0.7 https://rjrindex.com/articles/serplulimab-versus-placebo-plus-chemotherapy-as-first-line-treatment-for-extensive-stage-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementation-of-tarlatamab-treatment-for-small-cell-lung-cancer-using-an-outpatient-care-program 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-variation-in-molecular-profiles-of-tumors-from-metastatic-colon-cancer-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-pralsetinib-in-ireti-fusion-positive-solid-tumor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rapid-analysis-and-response-evaluation-of-combination-anti-neoplastic-agents-in-rare-tumors-rare-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genetic-testing-of-an-unselected-gastric-cancer-cohort-uncovering-germline-mutations-and-their-clin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-mortality-due-to-mesothelioma-among-older-adults-in-the-united-states-a-cdc-wond 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prediction-of-germline-brca-12-genes-pathogenetic-variants-from-ultrasound-images-of-healthy-ovarie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/updated-results-of-anlotinib-plus-benmelstobart-combined-with-nab-paclitaxel-and-cisplatin-as-first 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-biopsy-requirement-on-patient-enrollment-to-phase-i-trials-in-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-survival-outcomes-and-impact-of-treatment-modalities-in-rectal-squamous-cell-carcinom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/are-indulgent-lifestyle-practices-the-driving-determinants-behind-the-rising-cancer-rates-in-young-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/burkitt-lymphoma-incidence-in-relation-to-hiv-prevalence-in-united-states-a-regression-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-outcomes-in-patients-living-with-hiv-with-lung-cancer-and-treated-with-immune-checkpoint 2026-08-24 monthly 0.7 https://rjrindex.com/articles/frailty-in-lung-cancer-hospitalizations-identifying-critical-predictors-for-improved-patient-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-driven-risk-stratification-for-disease-progression-after-allo-sct-in-aml 2026-08-24 monthly 0.7 https://rjrindex.com/articles/understanding-psychosocial-wellbeing-and-concern-for-death-and-dying-insights-from-a-psycho-oncolog 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unveiling-the-promising-potential-of-luspatercept-in-transfusion-dependent-lower-risk-myelodysplasti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differences-in-peripheral-blood-immune-cells-composition-and-pathway-expression-between-non-hispanic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-preferences-for-survivorship-educational-programs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/well-being-pathway-we-path-an-italian-integrative-oncology-community-based-program-for-cancer-sur 2026-08-24 monthly 0.7 https://rjrindex.com/articles/beyond-study-cohorts-visualizing-patient-experience-informed-by-patient-reported-outcomes-pros-de 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-breast-tumors-and-the-tumor-immune-landscape-in-young-diverse-participants-of-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diversities-and-disparities-in-endometrial-carcinoma-ec-clinical-pathological-features-and-outcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/racial-disparity-in-the-incidence-and-mortality-of-young-adults-with-breast-cancer-a-nationwide-stu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pharmacotherapy-as-an-adjunct-to-behavioral-weight-loss-treatment-in-survivors-of-breast-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/disparities-in-nih-and-federal-cancer-research-funding-across-different-cancer-types 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ascomind-is-instant-asco-abstract-analysis-possible-with-ai-agents 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-clinical-and-socioeconomic-factors-on-survival-outcomes-in-non-small-cell-lung-cancer-a-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/precision-diagnostics-in-prostate-cancer-treatment-predict-a-phase-2-multi-arm-biomarker-based-st-1 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rural-urban-disparities-in-lung-cancer-screening-and-outcomes-a-comprehensive-study-of-texas-counti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-life-efficacy-and-safety-data-of-lorlatinib-treatment-in-ros-1-positive-advanced-non-small-cell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ffpe-rna-based-ddpcr-assay-an-effective-and-efficient-confirmation-for-imeti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-use-of-antibody-drug-conjugates-adcs-in-metastatic-bladder-cancer-analysis-of-10204-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-complemented-with-mini-patient-derived-xenografts-to-guide-individualized 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-prediction-models-for-5-year-and-10-year-ipsilateral-breast-tumor-recu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preoperative-axillary-us-and-mri-in-early-stage-breast-cancer-potential-to-prevent-unnecessary-axil 2026-08-24 monthly 0.7 https://rjrindex.com/articles/personalised-artificial-intelligence-based-approach-to-assessing-objective-response-to-immunotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impacting-quality-of-life-and-pancreatic-cancer-survivorship-through-a-telehealth-intervention 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-to-cancer-screening-through-national-telehealth-based-lung-and-colorectal-cancer-sc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/oncologists-perspectives-on-challenges-using-chemotherapy-immune-checkpoint-inhibitors-and-target 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-iv-magnesium-supplementation-in-reducing-adverse-cisplatin-associated-kidney-outcomes 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-artificial-intelligence-to-expert-physician-assessments-of-real-world-oncology-cases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-of-suicide-among-cancer-patients-a-seer-database-analysis-from-2000-to-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-socioeconomic-factors-of-follicular-thyroid-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-pelareorep-in-activating-anti-tumor-immunity-in-pdac 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ctdna-features-of-acquired-resistance-to-immunotherapy-in-advanced-nsclc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-envafolimab-plus-platinum-based-chemotherapy-as-neoadjuvant-therapy-in-resect 2026-08-24 monthly 0.7 https://rjrindex.com/articles/development-and-validation-of-a-postoperative-nomogram-for-predicting-survival-in-gallbladder-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-monocentric-analysis-of-escat-gene-actionability-detection-in-non-specific-molecular-profile-nsmp 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-of-advanced-stage-endometrial-cancer-by-residual-disease-and-mmr-status 2026-08-24 monthly 0.7 https://rjrindex.com/articles/utilization-of-large-language-models-to-facilitate-guideline-directed-therapy-of-genitourinary-cance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-automatic-ai-model-for-tumoral-burden-detection-and-segmentation-on-whole-body-mri-the-dipcan-st 2026-08-24 monthly 0.7 https://rjrindex.com/articles/final-patient-reported-outcomes-pros-in-unselected-men-receiving-talazoparib-tala-enzalutamide 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-ai-driven-auditing-of-mammography-reports-for-bi-rads-compliance 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-il-trial-to-assess-the-impact-of-v2-adrenergic-receptor-v2-ar-blockade-in-metastatic-tripl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dara-vcd-outcomes-of-frontline-therapy-for-light-chain-amyloidosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/incidence-and-survival-trends-in-early-onset-colorectal-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-open-label-multicenter-first-in-human-study-of-the-safety-tolerability-pharmacokinet 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-study-of-c019199-in-combination-with-sintilimab-in-patients-with-locally-recurrent-or-met 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-multisite-randomized-trial-of-an-advanced-pneumatic-compression-device-vs-usual-care-for-head-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-low-dose-capecitabine-and-erlotinib-in-treatment-of-recurrent-or-metastatic-head-and-neck-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nanoemulsions-loaded-with-5-fluorouracil-and-curcumin-as-a-strategy-for-enhancing-anticancer-activit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/low-dose-radiotherapy-combined-with-neoadjuvant-chemotherapy-and-an-anti-pd-1ctla-4-bispecific-anti 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-statins-on-the-mortality-of-long-term-survivors-of-nasopharyngeal-carcinoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-prediction-of-30-90-and-180-day-readmissions-in-head-and-neck-cancer-using-a-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/therapeutic-impact-of-novel-agents-in-patients-with-stage-iv-de-novo-hrveher2-ve-breast-cancer-re 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dissecting-two-decades-of-thyroid-carcinoma-survival-impact-of-gender-ethnicity-and-income-dispar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/colon-adjuvant-chemotherapy-based-on-evaluation-of-residual-disease-circulate-north-america-nrg-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/longitudinal-analysis-of-cancer-symptom-clusters-and-inflammatory-biomarkers-insights-into-quality 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-detection-of-lung-cancer-in-smokers-using-mirna-profiles-and-a-hybrid-deep-learning-framework 2026-08-24 monthly 0.7 https://rjrindex.com/articles/novel-risk-factors-predictive-of-anti-pd1-immune-checkpoint-inhibitor-associated-pulmonary-toxicity 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-multicenter-trial-of-the-combination-of-chidamide-and-toripalimab-in-patients-with-advan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-dice-of-clinical-trials-in-oncology-strategies-from-mathematical-permutation-combination-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-pilot-study-of-janus-kinase-1-jak1-inhibitor-itacitinib-for-treatment-refractory-sarcomas-leiom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploratory-study-on-the-impact-of-intestinal-low-dose-radiation-on-the-efficacy-and-prognosis-of-im 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prevalence-of-breast-cancer-across-racial-socioeconomic-and-regional-groups-in-the-us-analysis-of 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fecal-microbiota-transplantation-fmt-for-opioid-induced-constipation-oic-a-prospective-multice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/addressing-gender-disparities-in-oncology-and-hematology-education-insights-from-social-media-engag 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-utility-of-comprehensive-transcriptome-testing-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-bubble-effect-impact-of-asco-digital-promotion-on-ijournal-of-clinical-oncology 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-health-related-social-needs-hrsns-screening-and-targeted-intervention-through-patient-na 2026-08-24 monthly 0.7 https://rjrindex.com/articles/determining-primary-or-delayed-surgery-approach-in-fibrolamellar-carcinoma-of-the-liver-based-on-sta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-metabolic-signatures-in-epithelial-ovarian-cancer-diagnosis-the-application-of-nextgen-metab 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-platinum-resistance-in-recurrent-endometrial-cancer-a-retrospective-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-sequencing-of-biliary-tract-cancer-uncovering-the-genomic-origins-of-evolutionary-traj 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-mammaprint-and-clinical-outcomes-by-race-among-5000-individuals-with-hrher2-early-s 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-medical-debt-with-cancer-incidence-rates-in-the-us 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-pamiparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer-a-single-arm-prospe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-anti-steap1psma-adc-dxc008-assessment-of-anti-tumor-efficacy-pharmacokinetic-and-toxicity-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/assessing-the-impact-of-scalp-cooling-in-patients-receiving-trastuzumab-deruxtecan-for-metastatic-br 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterization-of-hereditary-tumor-risk-in-individuals-with-sdha-germline-variants 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-randomized-controlled-trial-of-cognitive-behavioral-therapy-and-bright-light-therapy-for-insomnia 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-prognostic-and-predictive-role-of-her2-amplificationoverexpression-and-iher2i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/pyrotinib-in-the-first-line-treatment-of-her2-positive-advanced-breast-cancer-results-from-the-pret 2026-08-24 monthly 0.7 https://rjrindex.com/articles/unmasking-the-link-between-sleep-apnea-and-lung-cancer-risk-a-retrospective-propensity-matched-coho 2026-08-24 monthly 0.7 https://rjrindex.com/articles/sequential-or-up-front-triple-combination-with-durvalumab-tremelimumab-and-bevacizumab-for-patient 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-intracerebroventricular-icv-delivery-of-bivalent-chimeric-antigen-receptor-car 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-safety-and-efficacy-data-of-icp-248-a-novel-bcl2-inhibitor-in-patients-with-relapsed-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/advancing-racial-representation-in-clinical-trials-an-analysis-of-53-asco-plenary-and-late-breaking 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retlirafusp-alfa-a-bifunctional-anti-pd-l1tgf-vrii-agent-plus-nab-paclitaxel-and-carboplatin-in-pre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-results-of-a-first-in-class-pd-1il-2-supa-biassup 2026-08-24 monthly 0.7 https://rjrindex.com/articles/one-button-push-fully-automated-psma-pet-quantification-correlation-with-progression-free-and-ove 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-open-label-first-in-human-study-of-abbv-969-a-dual-variable-antibody-drug-conjugate-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ipilimumab-and-nivolumab-after-disease-progression-on-single-agent-immunotherapy-in-mismatch-repair 2026-08-24 monthly 0.7 https://rjrindex.com/articles/harnessing-ehr-for-goals-of-care-the-role-of-electronic-alerts-for-care-optimization-in-gynecologic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gut-associated-checkpoint-as-a-prognostic-biomarker-in-metastatic-renal-cell-carcinoma-mrcc-resul 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cell-free-circulating-chromatin-profiling-for-epigenomic-characterization-of-mechanisms-of-response 2026-08-24 monthly 0.7 https://rjrindex.com/articles/isatuximab-isa-subcutaneous-sc-via-an-on-body-delivery-system-obds-vs-isa-intravenous-iv-pl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-open-label-study-of-brentuximab-vedotin-bv-pembrolizumab-pembro-in-patients-pts-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/an-open-label-multicenter-phase-12-study-of-peluntamig-pt217-an-anti-dll3anti-cd47-bispecific 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-outcomes-in-wsg-adapt-according-to-natalee-and-monarche-risk-criteria 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-clinical-update-of-ima203-an-autologous-tcr-t-targeting-prame-in-patients-with-pd1-refracto 2026-08-24 monthly 0.7 https://rjrindex.com/articles/elacestrant-ela-combinations-with-ribociclib-ribo-and-everolimus-eve-in-patients-pts-with-er 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mk-1084-for-kras-g12c-mutated-mut-metastatic-non-small-cell-lung-cancer-mnsclc-results-from-kan 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-2-study-to-confirm-safety-and-efficacy-of-mb-105-an-autologous-cd5-directed-car-t-cell-ther 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-trial-of-ozuriftamab-vedotin-ba3021-a-conditionally-binding-ror2-adc-in-patients-with-he 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-1-study-of-b7h3-car-t-cells-administered-intracranially-in-recurrent-glioblastoma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-trial-of-pembrolizumab-and-lenvatinib-in-recurrent-or-persistent-clear-cell-ovarian-carci 2026-08-24 monthly 0.7 https://rjrindex.com/articles/titanium-an-open-label-global-multicenter-phase-12-study-of-azd5492-a-first-in-class-subcutaneou 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rematch2201-a-phase-ii-study-on-reducing-surgical-margins-in-hpv-negative-advanced-hnscc-with-neoad 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-genomic-alterations-in-circulating-tumor-dna-ctdna-with-clinical-response-to-teliso 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-myelodysplastic-syndrome-and-myeloproliferative-neoplasms-in-patients-with-stable-coronary-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lacutamab-in-patients-with-relapsed-and-refractory-sezary-syndrome-long-term-follow-up-from-the-tel 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-1-study-of-shr-1826-a-c-met-directed-antibody-drug-conjugate-adc-in-advanced-solid-tumors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-phase-1-study-of-the-selective-protein-degrader-asp4396-in-patients-with-locally 2026-08-24 monthly 0.7 https://rjrindex.com/articles/cd-19-car-t-cell-therapy-in-adult-b-cell-all-patients-a-systematic-review-of-clinical-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/darolutamide-plus-goserelin-for-androgen-receptor-positive-salivary-gland-cancers-results-of-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rinatabart-sesutecan-rina-s-for-patients-with-advanced-endometrial-cancer-first-disclosure-from-d 2026-08-24 monthly 0.7 https://rjrindex.com/articles/first-in-human-study-of-jskn016-a-bispecific-anti-trop2her3-antibody-drug-conjugate-adc-antitum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/genomic-landscape-and-clinical-characteristics-of-patients-pts-with-neuroendocrine-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predicting-nodal-burden-after-neoadjuvant-chemotherapy-nac-with-circulating-tumor-ctdna-for-surg 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinical-outcomes-of-hemophagocytic-lymphohistiocytosis-in-patients-with-hiv-related-lymphomas-a-mu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/rethinking-future-workforce-planning-by-developing-novel-metrics-of-complexity-in-cancer-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-12-study-of-ksq-004ex-autologous-tumor-infiltrating-lymphocytes-engineered-to-inactivate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/health-related-social-needs-and-mortality-risk-among-united-states-veterans-with-non-small-cell-lung 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-geographic-information-system-gis-based-analysis-of-county-level-economic-and-social-vulnerabili 2026-08-24 monthly 0.7 https://rjrindex.com/articles/label-free-detection-of-visceral-pleural-invasion-in-lung-adenocarcinoma-using-multiphoton-microscop 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-neoadjuvant-toripalimab-plus-axitinib-in-renal-cell-carcinoma-with-tumor-thro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-of-whole-brain-low-dose-radiotherapy-combined-with-immune-checkpoint-inhibitor-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-first-in-human-study-of-atx-559-an-oral-inhibitor-of-dhx9-in-patients-with-adva 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-efficacy-of-ibrutinib-versus-other-covalent-bruton-tyrosine-kinase-inhibitors-cbtkis-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-tumor-response-on-1-month-ct-as-a-predictor-of-2-year-local-control-following-sbrt-in-pulmonar 2026-08-24 monthly 0.7 https://rjrindex.com/articles/differential-prognostic-significance-of-distant-and-locoregional-recurrence-on-survival-in-surgicall 2026-08-24 monthly 0.7 https://rjrindex.com/articles/r-spondin-3-as-an-independent-biomarker-and-potential-therapeutic-target-for-colon-cancer-immunother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/actionability-landscape-and-biomarker-utility-in-a-colorectal-cancer-alliance-cohort-initial-result 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-vitro-efficacy-of-cdk9-inhibitor-tambiciclib-sls009-in-asxl1-mutated-colorectal-cancer-cell-lin 2026-08-24 monthly 0.7 https://rjrindex.com/articles/targeted-agents-for-the-treatment-of-hormone-receptor-positive-human-epidermal-growth-factor-recep 2026-08-24 monthly 0.7 https://rjrindex.com/articles/lodestar-a-single-arm-phase-ii-study-of-rucaparib-in-solid-tumors-with-pathogenic-germline-or-somat 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-the-number-of-positive-lymph-nodes-lymph-node-ratio-and-log-odds-of-positive-lymph 2026-08-24 monthly 0.7 https://rjrindex.com/articles/correlation-of-carcinoembryonic-antigen-with-survival-in-patients-with-colorectal-liver-metastases-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-8-gene-signature-with-early-recurrence-in-resected-non-small-cell-lung-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trastuzumab-deruxtecan-t-dxd-in-her2-positive-advanced-breast-cancer-abc-with-active-cns-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prognostic-assessment-of-breast-cancer-using-clinical-and-pathological-variables-of-more-than-1-mill 2026-08-24 monthly 0.7 https://rjrindex.com/articles/whole-genome-based-circulating-tumor-dna-analysis-as-an-ultrasensitive-biomarker-in-pediatric-sarcom 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-clinicopathological-features-in-early-onset-breast-cancer-patients-with-and-without-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-sglt2-inhibitors-in-patients-with-multiple-myeloma-and-diabetes-mellitus 2026-08-24 monthly 0.7 https://rjrindex.com/articles/temporal-trends-in-the-incidence-of-multiple-myeloma-in-the-middle-east-and-north-africa-over-the-pa 2026-08-24 monthly 0.7 https://rjrindex.com/articles/retrospective-observational-study-to-describe-the-clinical-characteristics-management-and-outcome 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunologic-targeting-of-native-and-mutated-esr1-receptor-for-treatment-of-hormone-receptor-expressi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-multifunctional-biocatalytic-nanoenzyme-auc-at-scof-mn-on-photodynamic-immunoactivation-casca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trial-in-progress-a-phase-3-randomized-study-of-low-dose-intralesional-cemiplimab-versus-primary-su 2026-08-24 monthly 0.7 https://rjrindex.com/articles/trends-in-immune-related-adverse-event-reporting-among-multidisciplinary-cancer-programs 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-2-cohort-2-trial-in-progress-vabametkib-plus-lazertinib-for-patients-with-egfr-mutant-nsclc-w 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ii-exploratory-study-nct06208826-on-maintenance-immunotherapy-in-patients-with-resectable 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvantadjuvant-pembrolizumab-and-surgery-cesium-131-in-recurrent-hnscc-a-multicenter-phase 2026-08-24 monthly 0.7 https://rjrindex.com/articles/hyperlipidemia-as-adverse-event-of-lorlatinib-a-multicenter-cohort-study 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-ibiia-study-of-bat8010bat1006-an-anti-her2-monoclonal-antibody-exatecan-conjugate-combine-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/fall-risk-assessment-by-qtug-device-in-geriatric-cancer-patients-on-chemotherapy-at-a-tertiary-care 2026-08-24 monthly 0.7 https://rjrindex.com/articles/prospective-validation-of-the-cancer-and-aging-research-group-fall-risk-score-for-older-adults-with 2026-08-24 monthly 0.7 https://rjrindex.com/articles/association-of-medicaid-expansion-with-five-year-survival-after-cancer-diagnosis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/examining-the-relationship-between-multi-agent-immunosuppressive-therapy-for-immune-related-adverse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/industry-promotion-of-oncology-drugs-with-accelerated-approval-that-failed-confirmatory-trials 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gene-expression-profiling-plus-integrated-multidisciplinary-approach-to-detect-new-generation-risk-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/improving-access-and-communication-of-rural-cancer-patients-through-enhanced-usage-of-patient-portal 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exploring-the-role-of-progastricsinpepsinogen-c-pgc-in-gastric-carcinogenesis-a-south-asian-outl 2026-08-24 monthly 0.7 https://rjrindex.com/articles/falcon-exact-sciences-multicancer-early-detection-mced-real-world-evidence-rwe-registry 2026-08-24 monthly 0.7 https://rjrindex.com/articles/early-adverse-symptoms-to-predict-response-to-treatment-among-patients-in-the-i-spy-trial 2026-08-24 monthly 0.7 https://rjrindex.com/articles/expanding-uptake-of-cervical-cancer-screening-feasibility-and-acceptability-of-menstrual-blood-base 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-efficacy-and-safety-of-surufatinib-monotherapy-as-a-third-line-treatment-for-advanced-hepatocell 2026-08-24 monthly 0.7 https://rjrindex.com/articles/guide-g-an-artificial-intelligence-powered-platform-for-dynamic-nccn-guideline-visualization-in-bre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effectiveness-and-safety-of-combined-therapy-with-pemetrexed-and-bevacizumab-in-recurrent-and-metast 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proton-pump-inhibitors-and-clinical-outcomes-in-hepatocellular-carcinoma-patients-a-propensity-scor 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mirnas-expression-as-predictive-biomarkers-in-recurrentmetastatic-cervical-cancer-the-nrg-oncolo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/doacs-vs-warfarin-rethinking-anticoagulation-strategies-for-portal-vein-thrombosis-prophylaxis-in-p 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-alterations-identified-in-a-phase-1-study-of-fostamatinib-plus-paclitaxel-in-platinum-resi 2026-08-24 monthly 0.7 https://rjrindex.com/articles/individual-and-contextual-factors-associated-with-incidence-of-ovarian-cancer-in-the-united-states 2026-08-24 monthly 0.7 https://rjrindex.com/articles/circulating-tumor-dna-based-genomic-profiling-and-real-world-outcomes-in-cancer-of-unknown-primary 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neuroendocrine-neoplasm-a-10-year-retrospective-review-of-a-single-center-experience 2026-08-24 monthly 0.7 https://rjrindex.com/articles/evaluating-the-impact-of-copd-exacerbations-on-survival-outcomes-in-non-small-cell-lung-cancer-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/demographic-and-temporal-trends-in-stroke-related-mortality-in-women-with-breast-cancer-in-the-unite 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-pirfenidone-in-the-primary-prophylaxis-of-lung-cancer-in-idiopathic-pulmonary-fibrosis-patie 2026-08-24 monthly 0.7 https://rjrindex.com/articles/diagnostic-accuracy-of-machine-learning-models-in-glioma-classification-a-meta-analysis 2026-08-24 monthly 0.7 https://rjrindex.com/articles/meat-consumption-and-colorectal-cancer-risk-a-comprehensive-meta-analysis-of-red-processed-and-to 2026-08-24 monthly 0.7 https://rjrindex.com/articles/in-silico-evaluation-of-the-interaction-of-p-gp-and-3a4-substrates-with-the-wee1-inhibitor-debio-012 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-anlotinib-combined-with-gemcitabine-and-docetaxel-for-recurrent-or-metastatic 2026-08-24 monthly 0.7 https://rjrindex.com/articles/clinico-genomic-characterization-of-ipalb2i-mutated-pancreatic-adenoca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/machine-learning-and-survival-analysis-in-gallbladder-adenocarcinoma-gba-key-findings 2026-08-24 monthly 0.7 https://rjrindex.com/articles/successful-intervention-to-bridge-the-knowledge-gap-in-recognizing-and-managing-chemotherapy-hyperse 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-enhanced-literature-review-comparing-advanced-pancreatic-and-gastric-cancer-trial-outcomes-by-pe 2026-08-24 monthly 0.7 https://rjrindex.com/articles/patient-perspectives-on-nonmelanoma-skin-cancer-care-insights-into-treatment-barriers-and-healthc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ibrca12i-and-ipalb2i-short-variants-svs-contributed 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-impact-of-firstline-immunotherapy-and-tyrosine-kinase-inhibitors-combinations-versus-sunitinib-o 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-tp53-as-an-indicator-of-poor-survival-in-neoadjuvant-treated-triple-negative-breast-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/use-of-baffr-car-t-to-treat-b-cell-leukemialymphoma-and-auto-immune-diseases 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-efficacy-of-darolutamide-in-combination-with-androgen-deprivation-therapy-for-prostate-ca 2026-08-24 monthly 0.7 https://rjrindex.com/articles/nucleophosmin-inpm1i-genomic-alterations-ga-in-acute-myeloid-leuk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/overall-survival-in-metastatic-castration-resistant-prostate-cancer-mcrpc-a-retrospective-electro 2026-08-24 monthly 0.7 https://rjrindex.com/articles/predictive-associations-between-serum-dehydroepiandrosterone-sulfate-dheas-and-race-among-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-characterization-of-i-icdk12i-i 2026-08-24 monthly 0.7 https://rjrindex.com/articles/next-generation-sequencing-ngs-of-malignant-effusions-and-comparison-to-blood-liquid-biopsy-ctdna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-declining-but-divided-fight-against-genital-organ-neoplasms-who-is-still-left-behind 2026-08-24 monthly 0.7 https://rjrindex.com/articles/plasma-angptl3-apo-ciii-leptin-and-lipid-levels-in-patients-with-metastatic-prostate-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-immune-profiling-of-breast-cancer-from-pregnancy-to-postpartum-insights-into-the-tumo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/interferon-signaling-and-outcomes-in-triple-negative-breast-cancer-tnbc-in-finxx-calgb-40603-all 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-analysis-of-primary-tumor-transcriptomes-in-patients-subsequently-treated-with-parp-inhib 2026-08-24 monthly 0.7 https://rjrindex.com/articles/difference-in-survival-outcomes-between-de-novo-vs-therapy-related-neuroendocrine-cancer-of-prostate 2026-08-24 monthly 0.7 https://rjrindex.com/articles/role-of-systematic-biopsies-in-suspected-prostate-carcinoma-patients-and-analysis-of-gleason-grade-g 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-pre-lymphodepletion-pre-ld-and-day-30-m1-immune-cell-counts-on-outcomes-of-car-t-thera 2026-08-24 monthly 0.7 https://rjrindex.com/articles/profiling-dna-damage-response-in-atmbrca2-carriers-to-inform-hereditary-cancer-risk 2026-08-24 monthly 0.7 https://rjrindex.com/articles/site-specific-analysis-of-treatment-modalities-and-survival-in-brain-metastases-from-neuroendocrine 2026-08-24 monthly 0.7 https://rjrindex.com/articles/characterizing-functional-connectivity-in-brain-tumor-patients 2026-08-24 monthly 0.7 https://rjrindex.com/articles/risk-of-intracranial-hemorrhage-with-doacs-vs-lmwh-in-patients-with-cancer-associated-thrombosis-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/exome-analysis-of-over-5000-esophagogastric-cancers 2026-08-24 monthly 0.7 https://rjrindex.com/articles/gabrp-as-a-biomarker-for-predicting-anti-pd1-therapeutic-efficacy-in-advanced-gastric-cancer-wjog10 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effects-of-the-covid-19-pandemic-on-staging-and-treatment-patterns-in-non-small-cell-lung-cancer-a 2026-08-24 monthly 0.7 https://rjrindex.com/articles/immunorare-sup5sup-a-national-platform-of-5-academic-phase-ii-trials-2 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-dose-dense-versus-standard-neoadjuvant-chemotherapy-for-her2-negative-breast-cancer-r 2026-08-24 monthly 0.7 https://rjrindex.com/articles/time-to-subsequent-therapy-in-patients-pts-with-primary-advanced-or-recurrent-endometrial-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/proteomic-signatures-of-biofluid-derived-extracellular-vesicles-for-benign-and-malignant-ovarian-tum 2026-08-24 monthly 0.7 https://rjrindex.com/articles/preliminary-results-of-anlotinib-and-penpulimab-anti-pd1-combined-with-gemox-in-first-line-treatme 2026-08-24 monthly 0.7 https://rjrindex.com/articles/real-world-assessment-of-breast-cancer-risk-following-hormonal-therapy-in-endometriosis-a-global-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/chemotherapy-induced-modulation-of-brain-glucose-metabolism-in-leukemia-patients-a-retrospective-co 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-phase-iaib-study-of-talazoparib-in-combination-with-tazemetostat-in-metastatic-castration-resista 2026-08-24 monthly 0.7 https://rjrindex.com/articles/epidemiology-treatment-patterns-and-survival-outcomes-of-spermatocytic-seminoma-a-national-cancer 2026-08-24 monthly 0.7 https://rjrindex.com/articles/change-in-practice-patterns-over-time-for-endocrine-therapy-et-and-radiation-therapy-rt-in-women 2026-08-24 monthly 0.7 https://rjrindex.com/articles/experiences-and-preferences-of-cancer-survivors-across-the-immunotherapy-journey 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparative-outcomes-of-abiraterone-and-androgen-receptor-inhibitors-arpis-in-metastatic-castratio 2026-08-24 monthly 0.7 https://rjrindex.com/articles/factors-associated-with-occurrence-of-acute-leukemias-and-myelodyplastic-neoplasms-as-seen-at-the-ke 2026-08-24 monthly 0.7 https://rjrindex.com/articles/outcomes-in-bone-marrow-transplant-recipients-with-and-without-diabetes-a-propensity-matched-analys 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bridging-the-gap-palliative-care-outcomes-in-academic-versus-community-centers-for-advanced-non-sma 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-trial-of-health-coaching-based-navigation-after-breast-cancer-treatment 2026-08-24 monthly 0.7 https://rjrindex.com/articles/onpoint-development-of-an-open-navigator-through-precision-oncology-informatics-technology-to-suppo 2026-08-24 monthly 0.7 https://rjrindex.com/articles/metaplastic-breast-cancer-clinical-and-prognostic-features 2026-08-24 monthly 0.7 https://rjrindex.com/articles/levels-of-immune-responses-in-tertiary-lymphoid-structures-of-non-small-cell-lung-cancer-nsclc-and 2026-08-24 monthly 0.7 https://rjrindex.com/articles/multiple-immune-related-adverse-events-among-patients-with-melanoma-patterns-and-risk-factors 2026-08-24 monthly 0.7 https://rjrindex.com/articles/mutational-profiling-of-appendiceal-tumors-from-diagnostic-specimens-and-circulating-tumor-dna 2026-08-24 monthly 0.7 https://rjrindex.com/articles/how-to-improve-efficiency-in-io-clinical-trials-comprehensive-analysis-of-a-decade-long-reporting-b 2026-08-24 monthly 0.7 https://rjrindex.com/articles/feasibility-of-half-dose-dual-targeted-therapy-in-advanced-solid-tumors-with-ngs-proven-actionable-t 2026-08-24 monthly 0.7 https://rjrindex.com/articles/united-states-treatment-pattern-response-to-carboplatin-and-cisplatin-shortages 2026-08-24 monthly 0.7 https://rjrindex.com/articles/effect-of-body-mass-index-on-the-prognostic-impact-of-progesterone-receptor-in-postmenopausal-erher 2026-08-24 monthly 0.7 https://rjrindex.com/articles/a-systemic-trend-analysis-of-young-onset-esophageal-cancer-in-american-population-2012-2021 2026-08-24 monthly 0.7 https://rjrindex.com/articles/impact-of-great-circle-distance-on-breast-cancer-survival-in-ncdb 2026-08-24 monthly 0.7 https://rjrindex.com/articles/comparison-of-dual-vs-triple-oral-metronomic-chemotherapy-using-methotrexate-celecoxib-with-or-wit 2026-08-24 monthly 0.7 https://rjrindex.com/articles/atropisomeric-pyrrolopyrimidine-inhibitor-as-a-targeted-approach-for-ret-tyrosine-kinase-in-neurobla 2026-08-24 monthly 0.7 https://rjrindex.com/articles/safety-and-tolerability-of-intraventricular-carv3-team-e-t-cells-following-lymphodepleting-chemother 2026-08-24 monthly 0.7 https://rjrindex.com/articles/investigating-a-biopsychosocial-model-of-fatigue-in-patients-with-neuroendocrine-neoplasms 2026-08-24 monthly 0.7 https://rjrindex.com/articles/phase-ii-trial-of-neoadjuvant-nivolumab-and-sox-in-resectable-gastricgastroesophageal-junction-canc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/stromal-sarcoma-nos-a-national-cancer-database-analysis-of-patient-demographics-and-survival 2026-08-24 monthly 0.7 https://rjrindex.com/articles/molecular-and-clinical-characterization-of-klk2-mrna-expression-in-prostate-cancer-pc 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bria-imt-checkpoint-inhibitor-phase-iii-survival-results-compared-to-benchmark-trials-in-metasta 2026-08-24 monthly 0.7 https://rjrindex.com/articles/bolstering-access-to-clinical-trials-sociodemographic-characteristics-of-patients-enrolled-in-inter 2026-08-24 monthly 0.7 https://rjrindex.com/articles/implementing-the-bispecific-outpatient-safe-step-up-boss-program-for-elranatamab-in-ambulatory-tre 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neoadjuvant-chemotherapy-and-surgery-for-rectal-cancer-omission-of-radiation-in-clinical-practice 2026-08-24 monthly 0.7 https://rjrindex.com/articles/efficacy-and-safety-outcomes-of-obecabtagene-autoleucel-obe-cel-stratified-by-age-in-patients-pts 2026-08-24 monthly 0.7 https://rjrindex.com/articles/artificial-intelligence-based-music-therapy-intervention-in-cancer-patients-undergoing-chemotherapy 2026-08-24 monthly 0.7 https://rjrindex.com/articles/dreamm-8-study-of-belantamab-mafodotin-plus-pomalidomide-and-dexamethasone-bpd-vs-pomalidomide-plu 2026-08-24 monthly 0.7 https://rjrindex.com/articles/ai-powered-quantification-of-tumor-infiltrating-lymphocytes-from-hampe-stained-images-in-ovarian-c 2026-08-24 monthly 0.7 https://rjrindex.com/articles/neladalkib-nvl-655-a-highly-selective-anaplastic-lymphoma-kinase-alk-inhibitor-compared-to-ale 2026-08-24 monthly 0.7 https://rjrindex.com/articles/the-risk-of-venous-and-arterial-thrombosis-in-polycythemia-vera-patients-with-secondary-malignancies 2026-08-24 monthly 0.7